書籍詳細

chapter1 細胞

P.24 掲載の参考文献

• 1) 山田安正:現在の病理学. 第1版, 金原出版, 東京, 1981, p. 272-283

• 2) Arias, M. I., Jakoby, B. W., Popper, H. et al.:The Liver, Biology and Pathobiology, Second Edt, Raven Press, New York, 1982, p. 9-46

• 3) 渡辺明治:図解病態のしくみ, 肝臓病学1:肝臓の形態と機能. medicina 29:344-352, 1992

• 4) Ramadori, G., Sipr, J. D., Dinarello, C. A. et al.:Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL 1. J. Exp. Med. 162:930-942, 1985

• 5) Kobsel, N., Ramadori, G.:Human Hepatoma cells synthesize and secrete lysozyme:Modulation by cytokines.,Hepatology 19:1182-1188, 1994

• 6) Hoofnagle, J. H., Mullen, K. D., Jones, D. B.:Treatment of chronic non-A non-B hepatitis with recombinant human alpha interferon. N. Engl. J. Med. 315:1575-1578, 1986
  pubmed

• 7) Gilles, P. N., Guerrette, D. L, Ulevitch, R. J. et al.:HBsAg sensitizes the hepatocyte to injury by physiological concentrations of interferon-y. Hepatology 16:655-663, 1992

• 8) Volpes, R., van den Oord, J. J., Vos, R. D. et al.:Hepatic expressionof type A and type B receptors for tumor necrosis factor. J. Hepatol. 14:361-369, 1992

• 9) Morita, M., Watanabe, Y., Akaike, T.:Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19:426-431, 1994

• 10) Horiike, N., Onji, M., Kumon, I. et al.:Intercellular adhesion molecule-1 expression on the hepatocyte membrane of the patient with chronic hepatitis B and C. Liver 13:10-14, 1993

• 11) Doi, F., Goya, T., Torisu, M. et al:Potential role of hepatic macrophages in neutrophil-mediated liver injery in rats with sepsis. Hepato logy 17:1086-1094, 1993

• 12) Lewis, K. O., Paton, A.:Could superoxide cause cirrhosis. Lancet 2:188-189, 1982
  pubmed

• 13) Li, Y., Togashi, Y., Sato, S. et al.:Spontaneous hepatic copper accumulation in Long-Evans cinnamon rats with hereditary hepatitis:Amodel of Wilson:s disease. J. Clin. Invest. 87:1858-1861, 1991

• 14) 内田俊和:肝細胞の病理, 第1版, HBJ出版, 東京, 1992

• 15) Lohr, H., Trichl, U., Paralla, T. et al.:Liver infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin. Exp. Immunol. 88:45-49, 1992

• 16) Ferrari, C., Cavalli, A., Penna, A. et al.:Fine specificity of the human T-cell response to the hepatitis B virus preS 1 antigen. Gastroenterology 103:255-263, 1992

• 17) Missale, G., Redeker, A., Person, J. et al:HLA-A 31 and HLA-Aw 68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during active viral hepatitis. J. Exp.Med. 17:751-762, 1993

• 18) Koziel, M. J., Dudley, D., Wong, J. T. et al.:Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344, 1992
  pubmed

• 19) Botarelli, P., Brunetto, M. R., Minutello, M. A. et al.:T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580-587, 1993
  pubmed

• 20) Ferrari, C., Valli, A., Galati, L. et al.:T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286-295, 1994

• 21) Hoerner, M., Behrena, U. J., Worner, T. M. et al.:The role of alchoholism and liver disease in serum antibody against acetaldehyde adducts. Hepatology 8:569-574, 1988

• 22) Benedetti, A., Jezequel, A. M., Orlandi, A.:A quantitative evaluation of apoptotic bodies in rat liver. Liver 8:172-177, 1988

• 23) Itoh, N., Yomehara, S., Ishii, A. et al:The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-234, 1991

• 24) Yonehara, S., Ishii, A., Yonehara, M.:A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of human necrosis factor. J. Exp. Med. 169:1747-1756, 1989

• 25) Ogasawara, J., Watanabe-Hukunaga, R., Adachi, M. et al.:Lethal effect of the anti-fas antibody in mice. Nature 364:806-809, 1993

• 26) Suda, T., Takahashi, T., Golstein, P. et al.:Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
  pubmed

• 27) Hiramatsu, N., Hayashi, N., Katayama, K. et al.:Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.. Hepatology 19:1354-1359, 1994

• 28) Oltvai, Z. N., Milliman, L. C., Korsmeyer, S. J.:Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609-619, 1993

P.36 掲載の参考文献

• 1) Kupffer, C. V.:Uber Sternzellen in der Leber. Arch. Mikrosk. Anat. 12:352-358, 1876

• 2) Gale, R. P., Sparkes, R. S., Golde, D. W.:Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science 201:937-938, 1978
  pubmed

• 3) Wisse, E.:Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells.J. Ultrastruct. Res. 46:393-426, 1974
  pubmed

• 4) Decker, K., Busam, K.:Kupffer cell activation by endotoxin and virus. In Cells of the Hepatic Sinusoid. Vol.3. (Wisse, E., Knook, D. L, McCuskey, R. S. eds), Kupffer Cell Foundation, The Netherlands, 1991, p. 405-409

• 5) Adachi, Y., Arii, S., Monden, K. et al.:Interleukin 2 receptor expression on Kupffer cells:The mechanism of activation of Kupffer cells by BRMs. In Cells of the Hepatic Sinusoid. Vol. 3. (Wisse, E., Knook, D. L, McCuskey, R. S. eds.), Kupffer Cell Foundation, The Netherlands, 1991, p. 16-18

• 6) Tanner, A. R., Keyhani, A., Reiner, R. et. al.:Proteolytic enzymes released by liver macrophages may produce hepatic injury in a rat model of hepatic damage. Gastroenterology 80:647-654, 1981

• 7) Tanner, A. R.:The influence of endotoxin in vitro on hepatic macrophage lysosomal enzyme release in different rat models of hepatic injury. Liver 3:151-160, 1983
  pubmed

• 8) Shirahama, M., Ishibasi, H., Tsuchiya, Y. et al.:Kinetics and parameters of the induction of interleukin l secretion by rat Kupffer cells. J. Clin. Lab. Immunol. 27:127-132, 1988

• 9) Kunkel, S. L., Chensue, S. W., Phan, S. H.:Prostaglandins as endogeneous mediators of interleukin-1 production. J.,lmmunol. 136:186-192, 1986
  pubmed

• 10) Decker, K.:Eicosanoids, signal molecules of liver cells. Semin. Liver Dis. 5:175-190, 1985
  pubmed

• 11) Pabst, M. J., Johnston, R. B.:Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J. Exp. Med. 151:101-114, 1980

• 12) Yanagisawa, K., Kurihara, H., Kimura, S. et al.:Anovel potent vasoconstrictor peptide produced by vascular endothelial cells. Natu re 332:411-415, 1988

• 13) Kuiper, J., Zijlstra, F. J., Kamps, J. A. A. M. et al.:Identification of prostagrandin D 2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochem. Biophys. Acta 959:143-152, 1988

• 14) Libby, P., Ordovas, J. M., Auger, K. R. et al.:Endotoxin and tumor necrosis factor induce inter-leukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124:179-185, 1986

• 15) Matsuoka, K., Nakamura, T.:Hepatocyte growth factor:Molecular structure and implications for a central role in liver regeneration. J. Gastroenterol. Hepatol. 6:509-519, 1991

• 16) Smedsrod, B., Pertoft, H., Gustafson, S. et al.:Scavenger functions of the liver endothelial cell. Biochem. J. 266:313-327, 1990
  pubmed

• 17) Van Berkel, T. J. C., De Rijke, Y. B., Kruijt, J. K.:Different fate in vivo of oxidatively modified low density lipoprotein and acetylated Iow density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J.,Biol. Chem. 266:2282-2289, 1991

• 18) Forsberg, N., Gustafson, S.:Characterization and purification of the hyaluronan-receptor on liver endothelial cells. Biochem. Biophys. Acta 1078:12-18, 1991
  pubmed

• 19) Ito, T., Nemoto, M.:Uber die Kupfferschen Stornzellen und die Fettspeicherungszellen (fat storing cells) in der Blutkapillarenwand der menschlichen Leber. Okajima Folia. Anat.Jpn. 24:243-258, 1952

• 20) 伊東俊夫:人のクップェル氏細胞と肝毛細血管壁に見られる脂肪摂取細胞の研究. 解剖誌26 (総会号):42, 1951

• 21) Moriwaki, H., Blaner, W. S., Piantedosi, R. et al.:Effects of dietary retinoid and triglyceride on the lipid composition of rat liver stellate cells and stellate cell lipid droplets. J. Lipid Res. 29:1523-1534, 1988
  pubmed

• 22) Yamada, M., Blaner, W. S., Soprano, D. R. et al.:Biochemical characteristics of isolated rat liver stellate cells.,Hepatology 7:1224-1229, 1987
  pubmed

• 23) McGee, JO' D., Patrick, R. S.:The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver inlury. Lab. Invest. 26:429-440, 1972

• 24) De Leeuw, A. M., McCarthy, S. P., Geerts, A. et. al.:Purified rat liver fatstoring cells in culture divide and contain collagen. Hepatology 4:392-403, 1984

• 25) Clement, B., Grimaud, J.-A., Campion, J.-P. et al.:Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 6:225-234, 1986
  pubmed

• 26) Milani, S., Herbst, H., Schuppan, D. et al.:In situ hybridization for procollagen types I, m, W mRNA in normal and fibrotic rat liver. Evidence for predominant expression in nonparenchymal liver cells. Hepatology 10:84-92, 1989

• 27) Nakatukasa, H., Evarts, R. P., Hsia, C.-C. et al.:Transforming growth factor-β1 and type l procolagen transcripts during regeneration and early fibrosis of rat liver., Lab. Invest. 63:171-180, 1990

• 28) Andus, T., Ramadori, G., Heinrich, P. C. et al.:Cultured Ito cells of rat liver express the α 2-macroglobulin gene. Eur. J. Biochem. 168:641-646, 1987

• 29) Senoo, H., Wake, K.:Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab. Invest. 52:182-194, 1985
  pubmed

• 30) Russel, R. M., Boyer, J. L, Bagheri, S. A. et. al.:Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. New Engl. J. Med. 291:435-440, 1974

• 31) Wisse, E., vant:Noordende, J. M., van der Meulen, J. et al.:The pit cell. Description of a new type of cell occuring in rat liver sinusoids and peripheral blood. Cell Tissue Res. 173:423-435, 1976
  pubmed

• 32) Kaneda, K., Wake, K.:Distribution and morphological characteristics of the pit cells of the rat. Cell Tissue. 233:485-505, 1983
  pubmed

• 33) Kaneda, K., Dan, C., Wake, K.:Pit cells as natural killer cells. Biomed. Res. 4:567-576, 1983

• 34) Vanderkerken, K., Bouwens, L, Neve, W. D. et al.:Origin and differentiation of hepatic natural killer cells (Pit cells) . Hepatology 18:919-925, 1993

• 35) Abo, T.:Extrathymic differentiation of T lymphocytes and its biological function. Biomed. Res. 13:1-39, 1992

• 36) Nolan, J. P.:The role of endotoxin in liver injury. Gastroenterology 69:1346-1356, 1975
  pubmed

• 37) Bhatnagar, R., Schirmer, R., Ernst, M. et al.:Superoxide release by zymosan-stimulated rat Kupffer cells in vitro. Eur. J. Biochem. 119:171-175, 1981
  pubmed

• 38) Minato, Y., Hasumura, Y., Takeuchi, J.:The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease., Hepatology 3:559-566, 1983
  pubmed

• 39) Bachem, M. G., Riess, U., Gressner, A. M.:Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem.,Biophys. Res. Commun. 162:708-714, 1989
  pubmed

• 40) Matuoka, M., Pham, N.-T., Tsukamoto, H.:Differential effects of interleukin-1 α, tumor necrosis factor α, and transforming growth factorβ1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9:71-78, 1989

• 41) Matsuoka, M., Tsukamoto, H.:Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factorβ:Implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599-605, 1990

• 42) Shiratori, Y., Teraoka, H., Matano, S. et al.:Kupffer cell function in chronic ethanol-fed rats.,Liver 9:351-359, 1989
  pubmed

• 43) McClain, C. J., Cohen, D. A.:Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349-351, 1989
  pubmed

• 44) Earnest, D. L., Sim, W. W., Kirckpatrick, D. M. et al.:Effects of ethanol and acetalhyde on Kupffer cell function. In Cells of the Hepatic Sinusoid. Vol 2. (Wisse, E., Knook, D. L., Decker, K. eds.), Kupffer Cell Foundation, The Netherlands, 1989, p. 325-329

• 45) Mak, K. M., Lieber, C. S.:Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol:Ascanning electron microscopic structure. Hepatology 4:386-391, 1984

• 46) Horn, T., Christoffersen, P., Henriksen, J. H.:Alcoholic liver injury-defenes tration in noncirrhotic livers-A scanning electron microscopic study. Hepatology 7:77-82, 1987

• 47) Mori, T., Okanoue, T., Sawa, Y. et al.:Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 17:891-897, 1993

• 48) Schaffer, F., Popper, H.:Capillarization of hepatic sinusoids in man. Gastroenterology 44:239-242, 1963

• 49) Bhunchet, E., Fujieda, K.:Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis:Amechanism to maintain liver blood flow. Hepatology 18:1450-1458, 1993

• 50) Leser, H. G., Andreeson, K., Gerok, W.:Interleukin-1 production of differently stimulated Kupffer cells isolated from murine and human livers. In:Cells of the Hepatic Sinusoid. Vol 2. (Wisse, E., Knook, D. L., Decker, K. eds.), Kupffer Cell Foundation, The Netherlands, 1989, p. 179-181

• 51) Feder, L. S., McCloskey, M. C., Laskin, D. L.:Characterization of interleukin-1 (IL-1) and interleukin-6 (IL-6) production by resident and lypopolysaccharide (LPS) activated hepatic macro phages and endothelial cells. In Cells of the Hepatic Sinusoid. Vol. 3. (Wisse, E., Knook, D. L., McCuskey, R. S. eds.), Kupffer Cell Foundation, The Netherlands, 1991, p. 37-39

• 52) Karck, U., Peters, T., Decker, K.:The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostagland in E 2 and dexamethasone. J. Hepatol. 7:352-361, 1988

• 53) Hagiwara, T., Suzuki, H., Kono, I. et al.:Regulation of fibronectin synthesis by interleukin l and interleukin 6 in rat hepatocytes. Am. J. Pathol 136:39-47, 1990

• 54) Meyer, D. H., Bachem, M. G., Gressner, A. M.:Kupffer cells regulate fat storing cell proliferation and proteoglycan synthesis via transforming growth factors (TGF α and TGF β) .,rn Cells of Hepatic Sinusoid. Vol. 3. (Wisse, E., Knook, D. L., McCuskey, R. S. eds.), Kupffer Cell Foundation, The Netherlands, 1991, p. 19-22

• 55) Matsuoka, M., Zhang, M. Y., Tsukamoto, H.:Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors:Implication in alcoholic liver fibrogenesis. Hepatology 11:175-182, 1990

P.50 掲載の参考文献

• 1) 佐々木博:急性肝内胆汁うっ滞. ウイルス肝炎. 第1版, 新興医学出版, 東京, 1983, p. 76-98

• 2) 山中正己:序-急性肝内胆汁うっ滞の発生機序と治療をめぐる最近の進歩-. 胆と膵 14:707-709, 1993

• 3) 織田正也, 塚田信廣, 小松弘一ほか:胆汁分泌とその異常. 臨床消化器内科 2:331-351, 1987

• 4) Ludwig, J.:Destructive small-duct biliary diseases:Current concepts and controversies. 肝臓病-今日の話題 (小幡裕編). 第1版, 中外医学社, 東京, 1991, p. 210-214

• 5) 佐々木博, 青山圭一, 宮林千春ほか:胆汁うっ滞と肝細胞障害. 肝胆膵 19:225-233, 1989

• 6) Popper, H.:Problems in the pathogenesis of intrahepatic cholestasis. Problems in Intrahepatic Cholestasis, 2nd Int. 1-7, Symp., Florence. Karger:Basel, 1979

• 7) 岡上武, 太田正治, 高見史朗:胆汁排泄と肝細胞骨格の役割-ギャップジャンクションと中間径フィラメントを中心に-. 胆と膵 14:733-737, 1993

• 8) Wiesner, R. H., LaRusso, N. F.:Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroen te ro logy 79:200-206, 1980

• 9) 渡辺俊明, 上村朝輝, 朝倉均ほか:原発性硬化性胆管炎の胆管病変. 胆と膵 10:975-984, 1989

• 10) Neuberger, J., Portmann, B., Macdougall, B. R. D. et al.:Recurrence of primary biliary cirrhosis after liver transplantation. N. Engl. J. Med. 306:1-4, 1982

• 11) Sherlock, S.:The syndrome of disappearing intrahepatic bileducts. Lancet ii:493-496, 1987

• 12) Desmet, V. J.:Intrahepatic bile ducts under the lens. J. Hepatol. 1:545-559, 1985

• 13) 三枝信, 奥平雅彦:胆管消失症候群とは. 肝胆膵 26:357-362, 1993

• 14) Joplin, R., Lindsay, J. D., Hubscher, S. G. et al.:Distribution of dihydrolipoamide acetyl transferase (E 2) in liver and portal lymph nodes of patients with primary biliary cirrhosis:An immunohistochemical study. Hepatology 14:442-447, 1991

• 15) Yamada, G., Hyodo, I., Tobe, K. et al.:Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6:385-391, 1986
  pubmed

• 16) 宮林千春, 樋口清博, 佐々木博:原発性胆汁性肝硬変. 臨床成人病 23:16-20, 1993

• 17) 佐々木博:特殊な肝硬変. 胆汁性肝硬変 (原発性, 続発性), 最新内科学体系49肝硬変 (井村祐夫, 尾形悦郎, 高久史麿ほか編), 第1版, 中山書店, 東京, 1991, p.327-353

• 18) Takacs, L, Szende, B., Montori, E. et al.:Expression of HLA-DR antigens on bile duct cells of rejected liver transplantation. Lancet ii:1500, 1993

• 19) Milio, F., Pignatelli, M., Mazzeo, V. et al.:Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone mar row transplantation. J. Hepatol. 5:182-189, 1987

• 20) 佐々木博, 青山圭一, 宮林千春ほか:薬物による肝障害の成因と分類. 臨牀消化器内科 4:1745-1754, 1989

• 21) Miyabayashi, C, Kojima, T., Inoue, K. et al.:Ultrastructural localization of type IV collagen, laminin and prolyl hydroxylase in biliary epithelial cells of rat liver following ligation of the common bile duct. Gastroenterol. Jpn. 22:354-369, 1987
  pubmed

• 22) 中沼安二:肝内胆管消失の病理. 胆と膵 10:945-952, 1989

• 23) 辻井正, 塚本昇:ALP高値. 綜合臨牀 37:1006-1009, 1988

• 24) 清水幸裕, 渡辺明治:肝疾患の検査法. Medicina 29:500-510, 1992

• 25) 小坂義種, 山舗昌由, 高瀬幸次郎ほか:LAP. 綜合臨牀 37:1010-1014, 1988

P.65 掲載の参考文献

• 1) 香川靖雄:膜受容体と細胞外情報伝達. 生体膜と疾患の分子生物学. 第1版, 南山堂, 東京, 1993, p.241-353

• 2) 本田律子, 門脇孝:インスリン受容体異常症の遺伝. Diabetes Frontier 3:327-338, 1992

• 3) Ross, R.:The pathogenesis of arterosclerosis-An update. N. Engl. J. Med. 314:488-500, 1986

• 4) Sporn, M. B., Roberts, A. B.:Autocrine secretion-10 years letter. Ann. Int. Med. 117:408-414, 1992

• 5) Jain, M. K.:Introduction to Biological Membranes. 2nd edition, John Wiley & Sons, New York, 1988

• 6) 春日雅人:細胞膜受容体を介するシグナル伝達. 情報伝達とその異常 (門脇孝編), 第1版, 羊土社, 東京, 1993, p.14-29

• 7) Aaronson, S. A.:Growth factor and cancer. Science 254:1146-1153, 1991
  pubmed

• 8) Matsuda, M., Mayer, B. J., Fukui, Y. et al.:Binding of transforming protein, p 47 gag-crk, to a broad range of phosphotyrosine-containing Proteins. Science 248:1537-1539, 1990

• 9) Fantl, W. J., Escobede, J. A., Martin, G. A. et al.:Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69:413-423, 1992

• 10) 斉藤春雄:チロシンポスファターゼの構造と機能. 実験医学 10:1260-1266, 1992

• 11) Simon, M. I., Strathmann, M. A., Gautam, N.:Diversity of Gprotein in signal transduction. Science 252:802-808, 1991

• 12) 小島至:カルシウムイオンの細胞内分布と調節. カルシウムと細胞情報. 第1版, 羊土社, 東京, 1992, p.17-30

• 13) 小島至:ホルモン作用とPIレスポンス. 情報伝達とその異常 (門脇孝編), 第1版, 羊土社, 東京, 1993, p.30-45

• 14) 磯部光章, 矢崎義雄:接着分子を通じた免疫応答とその機能阻害による免疫抑制. 実験医学 11:778-784, 1993

• 15) Schwartz, R. H.:A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356, 1990

• 16) 八木田秀雄:構造的にみた接着分子の分類. 接着分子(宮坂昌之編), 第1版, メジカルビュー社, 東京, 1991, p.8-22

• 17) 小沢政之:カドヘリンファミリー. Mebio 10:50-55, 1993

• 18) Volpes, R., van den Oord, J. J., Desmet, V. J.:Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 12:59-65, 1990
  pubmed

• 19) Adams, D., Mainolfi, E., Baura, P. et al.:Detection of circulating intracellular adhesion molecule 1 in chronic liver diseases. Hepatology 16:810-814, 1992

• 20) Zohrens, G., Armbrust, T., Pirzer, U. et al.:Intracellular adhesion molecule-1 concentration in sera of patient with acute and chronic liver disease:Relationship to disease activity and cirrhosis. Hepatology 18:798-802, 1993

• 21) Hynes, R.:Integrins:Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
  pubmed

• 22) 高田義一:インテグリン研究の最近の進歩. 実験医学 10:32-37, 1992

• 23) Schwartz, M. A., Lechene, C., Ingber, D. E.:Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5 β1, independent of cell shape. Proc. Natl. Acad. Sci. USA 88:7849-7853, 1991

• 24) Springer, T. A.:Adhesion receptor of the immune system. Natu re 346:425-434, 1990

• 25) Lawrence, M. B., Springer, T. A.:Leukocytes roll on a selectin at physiologic flow rates:Distinc tion from and prerequisite for adhesion through integrins. Cell 65:859-873, 1991

• 26) 宮園浩平:細胞増殖因子のバイオロジー. 第1版, 羊土社, 東京, 1992

• 27) Tanaka, A., Miyamoto, K., Minamoto, N. et al.:Cloning and characterization of an androgen-in duced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA 89:8928-8932, 1992

• 28) 秋山徹:細胞増殖因子による遺伝子発現制御機構. 細胞増殖因子の最前線 (門脇孝編), 第1版, 羊土社, 東京, 1993, p.56-68

• 29) 伊藤文詔:MAPキナーゼカスケイド. 細胞内シグナル伝達経路 (岡山博人編), 第1版, メジカルビュー社, 東京, 1994, p.106-115

• 30) 小島至:カルシウムイオンの細胞内分布と調節. カルシウムと細胞情報. 第1版, 羊土社, 東京, 1992, p.108-146

• 31) Matsumoto, K., Nakamura T.:Hepatocyte growth factor:Molecular structure, roles in liver re generation, and other biological function. Clin. Rev. Oncogen. 3:27-54, 1992

• 32) Matsumoto, K., Nakamura, T.:Roles of HGF as a pleiotropic factor in organ regeneration. Hepatocyte Growth Factor-Scatter Factor and c-Met Receptor (Golber, I. D. ed.), Birkhauser Verlag, Berlin, 1993, p. 225-249

• 33) Matsumoto, K., Tajima, H., Nakamura, T. et al.:Identification and charactarization of injurin an inducer of expression of the gene for hepatocyte growth factor. Proc. Natl. Acad.. Sci. USA 89:3800-3804, 1992

• 34) Kan, M., Huang, J., Mansson, P.-E. et al:Heparin-binding growth factor type 1 (acidic fibroblast growth factor):apotential biphasic autocrine and paracrine regulator of hepatocyte regeneration. 1) roc. Natl. Acad. Sci. USA 86:7432-7436, 1989

• 35) 安田宏, 小島至:アクチビン. フォリスタチン系による肝細胞増殖制御. 日消誌 90:302, 1993

chapter2 代謝

P.80 掲載の参考文献

• 1) 浪久利彦, 溝口靖紘, 石井裕正ほか:肝疾患とプロスタグランジン. 肝胆膵 22:267-277, 1991

• 2) 山下哲:生理的に重要な脂質. ハーバー・生化学 (上代淑人 監訳), 原書22版, 丸善, 東京, 1991, p.139-150

• 3) 早石修:プロスタグランジンの基礎と臨床, メディカルトリビューン, 東京, 1988, p.7-32

• 4) Vane, J. R.:Inhibition of prostagland in synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235, 1971

• 5) Nugteren, D. H., Hazelhof, E.:Isolation and popenies of intermediates in prostaglandin biosynthesis. Biochim. Biophys. A cta 326:448-461, 1973

• 6) Hamberg, M., Svensson, J., Wakabayashi, T. et al.:Isolation and structure of two prostaglandin endoperoxides that cause pletelet aggregation. Proc. Natl. Acad. Sci. USA 71:345-349, 1974

• 7) 室田誠逸:アラキドン酸カスケード. プロスタグランジンと病態 (室田誠逸編), 東京化学同人, 東京, 1986, p.277-281

• 8) Hamberg, M., Svensson, J., Samuelsson, B.:Thromboxanes:anew group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 72:2994-2998, 1975

• 9) Moncade, S., Gryglewski, R. J., Bunting, S. et al.:An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665, 1976

• 10) Orning, L, Hammarstrom, S., Samuelsson, B.:Leukotriene D:aslow reacting substance from rat basophilic leukemia cells. Proc. Natl. Acad. Sci. USA 177:2014-2017, 1980

• 11) 武富保:不飽和脂肪酸とエイコサノイドの代謝. ハーバー・生化学 (上代淑人 監訳), 原書22版, 丸善, 東京, 1991, p.227-234

• 12) 渡辺明治, 沖田美佐子:肝疾患の治療栄養学. 肝臓病と治療栄養, 第一出版, 東京, 1992, p.152-180

• 13) 島崎弘幸:高度不飽和脂肪酸の代謝異常. The Lipid 3:35-42, 1992

• 14) Kramer,R.M. :細胞質型ホスホリパーゼA2の構造と機能. 実験医学 11:1467-1474, 1991

• 15) 渡辺毅:プロスタグランジン, トロンボキサン, ロイコトリエン受容体の分子構造とその働き. 蛋白質 核酸 酵素 37:925-936, 1992

• 16) 香川靖雄:プロスタグランジン, オータコイドの受容体. イラストでみる生体膜と疾患の分子生物学, 南山堂, 東京, 1993, p.328-344

• 17) 伊東祐之, 広瀬卓男, 箱田博之:プロスタグランジン受容体の多様性. 実験医学 9:15-20, 1991

• 18) Decker, K.:Eicosanoids as signal molecules between hepatocytes and sinusoidal cells in modulation of liver cell expression. Proceedings of the 43 rd Falk Symposium (Reutter, W. et al. eds.), Basel, 1986, p. 397-409

• 19) 奥村忠芳, 斎藤国彦:肝細胞におけるアラキドン酸代謝. 肝胆膵 22:171-180, 1991

• 20) 河田則文, 溝口靖紘:肝類洞細胞におけるアラキドン酸カスケード. 肝胆膵 22:201-207, 1991

• 21) Decker, K.:Eicosanoids, signal molecules of liver cells. Sem. Liver Dis. 5:175-190, 1985

• 22) Puschel, G. P., Hespeling, U., Oppermann, M. et al.:Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C 3 a. Hepatology 18:1516-1521, 1993

• 23) Kuiper, J., Zijlstra, F. J., Kamps, J. A. A. M. et al.:Identification of prostaglandin D? as the major eicosanoid from liver endothelial and Kupffer cells. Biologica Biophys. Acta 959:143-152, 1988

• 24) Urade, Y., Ujihara M., Horiguchi, Y. et al.:The major source of endogenous prostaglandin D? production is likely antigen-presenting cells. Localization of glutathion-requiring prostaglandin D synthetase in histocytes, Dendric, and Kupffer cells in various rat tissues. J. Immunol. 143:2982-2989, 1989

• 25) 溝口靖紘, 河田則文:肝macrophageのprostaglandin合成に及ぼすbiological response modifierの影響. 肝類洞壁細胞研究の進歩5 (谷川久一編), 国際図書出版, 東京, 1992, p.135-139

• 26) Hagmann, W., Steffan, A. M., Kirn, A. et al.:Leukotriens as mediators in frogvirus 3-induced hepatitis in rats. Hepatology 7:732-736, 1988

• 27) Sakagami, Y., Mizoguchi, Y., Seki, S. et al.:Release of peptide leukotriens from rat Kupffer cells. Biochem. Biophys. Res. Commun. 156:217-221, 1988
  pubmed

• 28) Flisiak, R., Baraona, E., Li, J. et al.:Effects of ethanol on prostanoid production by liver fatstoring cells. Hepatology 18:153-159, 1993
  pubmed

• 29) Athari, A., Hanecke, K., Jungermann, K.:Prostaglandin F2α and D2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 20:142-148, 1994

• 30) 門奈丈之, 溝口靖紘, 河田則文:アラキドン酸カスケードと肝障害. 肝胆膵 19:191-200, 1989

• 31) Shiratori Y., Moriwaki H., Muto Y. et al:Production of leukotrien B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin. Gastroenterol. Jpn. 24:640-645, 1989
  pubmed

• 32) Tiegs, G., Wendel, A.:Leukotrien-mediated liver injury. Biochem. Pharmacol. 37:2569-2573, 1988
  pubmed

• 33) 溝口靖紘:急性肝不全の発症機序をめぐるトピックス. アラキドン酸カスケード関連物質. 臨床消化器内科 8:347-356, 1993

• 34) 門原留雄, 瀬川徹:肝障害とアラキドン酸カスケード. 肝胆膵 22:223-229, 1991

• 35) 石井良和:ケノデオキシコール酸の培養ラット肝細胞に及ぼす影響とProstaglandin E-の細胞保護作用について. 日消誌 82:108-117, 1985

• 36) 有井滋樹, 篠置哲, 足立幸人ほか:肝再生と肝硬変. 肝胆膵 22:241-249, 1991

• 37) Tsuji, H., Okamoto, Y., Kikuchi, E. et al.:Prostaglandin E, and rat liver regeneration. Gastroenterology 105:495-499, 1993

• 38) 佐藤信紘, 大井手弘純:肝血流とプロスタグランジン. 肝胆膵 22:191-200, 1991

• 39) Kikuchi, E., Fukui, H., Matsumoto, M. et al.:Effect of prostaglandin EI on experimental acute hepatic failure in rabbits:Prostaglandin EI prevents the development of multiple-organ failure. J. Hepatol. 20:478-482, 1994

• 40) 満岡聰, 大津留晶, 中田恵輔ほか:プロスタグランジンと肝細胞癌. 肝胆膵 22:251-254, 1991

• 41) Trevisani, A., Ferretti, E., Capuzzo, A. et al.:Elevated levels of prostaglandin E? in Yoshida hepatoma and the tumor growth by non-steroidal anti-inflammatory drugs. Br. J. Cancer 41:341-347, 1980
  pubmed

• 42) Cyran, J. LM. A., Lysz, T. W.:Prostaglandin biosynthetic capacity of hepatomas with different growth rates:Int. J. Biochem. 21:445-451, 1989

• 43) 板倉正幸, 野原隆彦, 中瀬明:in vivoおよびin vitroにおけるヒト肝細胞癌のPGE2産生能とその意義に関する実験的検討. 日消誌 86:227-236, 1989

• 44) Kobayashi, H., Ojima, M., Satoh, H.:Efffect of 6-keto-prostaglandin EI on ascitic hepatoma-130 沈励ocomparison with chemotherapeutic agents. Prostaglandins 29:255-268, 1985

P.91 掲載の参考文献

• 1) Goodman, D. S.:Vitamin A and retinoids in health and disease. N. Engl. J. Med. 310:1023-1031, 1984
  pubmed

• 2) Hendriks, H. F. J., Bosma, A., Brounwer, A.:Fat-storing cells:hyper-and hypovitaminosis A and the relationships with liver fibrosis. Semin. Liver Dis. 13:72-80, 1993

• 3) 武藤泰敏, 奥野正隆, 森脇久隆:ビタミンA. 臨床栄養の進歩1991 (岡田正ほか編), 光生館, 東京, 1991, p.22-34

• 4) 井廻道夫:ビタミン, 肝蔵の研究 (織田敏次ほか編), 同文書院, 東京, 1987, p.146-152

• 5) 和気健二郎:ビタミンAの細胞間転移. 肝の線維化・サイトカイン・ビタミン, 肝の生化学, 箱根シンポジウム3 (箱根シンポジウム記録刊行会 編), 中外医学社, 東京, 1988, p.114-118

• 6) Blomhoff, R., Berg, T., Norum, K. R.:Transfer of retinol from parenchymal to stellate cells in liver is mediated by retinol binding protein. Proc. Natl. Acad. Sci. USA 85:3455-3458, 1988
  pubmed

• 7) 森脇久隆:ビタミンA結合蛋白. 肝の線維化・サイトカイン・ビタミン, 肝の生化学, 箱根シンポジウム 3 (箱根シンポジウム記録刊行会 編), 中外医学社, 東京, 1988, p.119-126

• 8) 奥野正隆, 沼口沙登史, 森脇久隆ほか:細胞内結合蛋白の分子生物学. 日本臨牀 54:879-885, 1993

• 9) 四童子好広, 武藤泰敏:脂溶性ビタミン受容体の分子生物学. 日本臨牀 54:842-845, 1993

• 10) Petkovich, M., Brand, N. J., Krust, A. et al.:Ahuman retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450, 1988

• 11) Dolle, P., Ruberte, E., Kastner, P. et al.:Differential expression of genes encoding α, β and y retinoic acid receptors and CRABP in the developing limbs of the mouse. Nature 342:702-705, 1989

• 12) Levin, A. A., Sturzenbecker, L. J., Kazmer, S. et al.:9-Cis retinoic acid stereoisomer binds and ac tivates the nuclear receptor RXR α. Nature 355:359-361, 1992

• 13) Kasai, T., Moriwaki, H., Okuno, M. et al.:The clearance rate of chylomicron retinyl ester from plasma can be used to distinguish rats with cirrhosis from those with portacaval shunt. Hepato logy 17:125-130, 1993

• 14) Senoo, H., Wake, K.:Suppression of experimental hepatic fibrosis by administration of Vitamin A. Lab. Invest. 52:182-194, 1985
  pubmed

• 15) Seifert, W. F, Bosma, A., Brouwer, A. et al.:Vitamin A deficiency potentiates carbon tetra-chloide-induced liver fibrosis in rats. Hepatology 17:193-201, 1994

• 16) Hruban, Z., Russell, R. M., Boyer, J. L. et al.:Ultrastructural changes in livers of two patients with hypervitaminosis A. Am. J. Pathol 76:451-468, 1974
  pubmed

• 17) Lieber, C.:Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N. Engl. J. Jifed. 319:1639-1650, 1988

• 18) Lieber, C. S.:Alcohol and the liver:1994 update. Gastroenterology 106:1085-1105, 1994
  pubmed

• 19) Leo, M. A., Lieber, C. S.:Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 3:1-11, 1983
  pubmed

• 20) Leo, M. A., Rosman, A. S., Lieber, C.:Diferential depletion of carotenoids and tocopherol in liver disease. Hepatology 17:977-986, 1993

• 21) 田中信夫, 田中祥博, 阪本琢也ほか:癌の予防・ビタミン. 臨床成人病 22:42-47, 1992

• 22) 美濃真:レチノイン酸とビタミンEの代謝調節機構. 日本臨牀 54:871-877, 1993

• 23) Moriwaki, H., Muto, Y., Ninomiya, M. et al.:Inhibitory effects of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3:-methyl-N, N-dimethyl-4-aminoazobenzene. Gastroenterol. Jpn. 23:546-552, 1988
  pubmed

• 24) Okuno, M., Muto, Y., Moriwaki, H.:Inhibitory effect of acyclic retinoid (polyprenoic acid) on he-patic fibrosis in CCI4-treated rats. Gastroenterol. Jpn. 25:223-229, 1990

P.104 掲載の参考文献

• 1) 原田勝二:アルコール・アルデヒド脱水素酵素の遺伝子的多型. 代謝 28:目で見るページ, 1991

• 2) 高瀬修二郎, 高田昭:アルコール・アセトアルデヒド代謝と肝障害. 代謝 28:431-439, 1991

• 3) 倉敏郎, 石垣聖史, 藩紀良ほか:アルコール多飲者におけるグルタチオンS-トランスフェラーゼπ(GST-π)の変化. アルコール代謝と肝(アルコール代謝と肝研究会編), vol. 11, 東洋書店, 東京, 1992, p.39-42

• 4) 石井裕正, 竹川節男, 土本寛二:アルコール性肝障害の発生機序. 肝胆膵 14:17-27, 1987

• 5) Lieber, C. S.:Pathophysiology of alcoholic liver injury. Molec. Aspects Med. 10:107-146, 1988

• 6) 山田真和:アルコールと細胞膜流動性. 代謝 28:441-449, 1991

• 7) 林紀夫, 田中由字志, 金子晃ほか:アルコールと細胞内カルシウム. 代謝 28:453-460, 1991

• 8) 石井裕正, 土本寛二, 横山裕一ほか:アルコール性肝障害と免疫異常. 代謝 28:461-468, 1991

• 9) Chedid, A., Mendenhall, C. L, Moritz, T. E. et al.:Cell-mediated hepatic injury in alcoholic liver disease. Gastroenterology 105:254-266, 1993
  pubmed

• 10) 佐藤信紘:肝微小循環とアルコール性肝障害. 代謝 28:469-476, 1991

• 11) 石井裕正:飲酒の生化学的マーカー. 日本臨牀 46:1805-1810, 1988
  Medical*Online

• 12) Deviere, J., Content, J., Denys, C. et al:Immunoglobulin A and interleukin 6 form a positivesecretory feedback loop:Astudy of normal subjects and alcoholic cirrhotics. Gastroenterology 103:1296-1301, 1992

• 13) 武内重五郎 (編):アルコール性肝障害. 本邦における臨床とその特徴, 朝倉書店, 1988

• 14) 康山俊学:アルコール多飲者とHCV感染. 日本臨牀 49:179-185, 1991

• 15) 高田昭:内科学の展望 (第19回) 肝胆膵疾患の診断と治療-最近の進歩-アルコール性肝障害の診断と治療. 日内誌 81:12-17, 1992

• 16) 王健松, 堤幹宏, 高瀬修二郎ほか:アルコール性肝障害の生化学的マーカーの分析-特に血清transferrinの微小変異の意義について-. アルコール代謝と肝 (アルコール代謝と肝研究会編), vol.11, 東洋書店, 東京, 1992, p.64-69

• 17) 中西顛央:アルコールの薬理学. 日本臨牀 46:1661-1665, 1988

• 18) 田中三千雄:アルコールと消化管病変. 消化器内視鏡 4:17-20, 1992

• 19) 山雄健次, 中澤三郎, 芳野純治ほか:日本人のアルコール性慢性膵炎. 消化器内視鏡 4:97-104, 1992

• 20) 岩田誠:アルコール関連中枢神経疾患. 日本臨牀 46:1686-1690, 1988
  Medical*Online

• 21) 高木繁治:脳血管障害. 日本臨牀 46:1691-1695, 1988
  Medical*Online

• 22) 杉下靖郎, 小川剛, 山口巌ほか:アルコールと心疾患. 日本臨牀 46:1701-1705, 1988
  Medical*Online

P.123 掲載の参考文献

• 1) Gressner, A. M., Bachem, M. G.:Cellular sources of noncollagenous matrix proteins:role of fat-storing cells in fibrogenesis. Seminars in,Liver Disease 10:30-46, 1990
  pubmed

• 2) Schuppan, D.:Structure of the extracellular matrix in normal and fibrotic liver:collagens and glycoproteins. Sem ina rs in Liver Disease 10:1-10, 1990

• 3) Oh, S. P., Kamagata, Y., Muragaki, Y. et al.:Isolation and sequencing of cDNAs for proteins withmultiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. USA 91:4229-4233, 1994

• 4) 林利彦:細胞外マトリックス成分の構造と機能. 細胞外マトリックスのバイオサイエンスとバイオテクノロジー (藤本大三郎編), アイピーシー, 東京, 1991, p.5-47

• 5) 畑隆一郎:細胞外マトリックスの合成と分解細胞外マトリックスのバイオサイエンスとバイオテクノロジー (藤本大三郎編), アイピーシー, 東京, 1991, p.165-191

• 6) Takahara, T., Kojima, T., Miyabayashi, C. et al.:Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab. Invest. 59:509-521, 1988
  pubmed

• 7) Nakayama, Y., Takahara, T., Miyabayashi, C. et al.:Ultrastructural localization of type IV collagen and laminin in the Disse space of rat liver with carbon tetrachloride induced fibrosis. Liver 11:260-271, 1991
  pubmed

• 8) Birk, D. E., Fitch, J. M., Babiarz, J. P. et al.:Collagen type I and type V are present in the same fibril in the avian corneal stroma. J. Cell Biol. 106:999-1006, 1988
  pubmed

• 9) Keene, D. R., Engvall, E., Glanville, R. W.:Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J. Cell Biol. 107:1995-2006, 1988
  pubmed

• 10) Loreal, O., Clement, B., Schuppan, D. et al.:Distribution and cellular origin of collagen VI during development and in cirrhosis. Gastroenterology 102:980-987, 1992
  pubmed

• 11) Inuzuka, S., Ueno, T., Torimura, T. et al.:Immunohistochemistry of the hepatic extracellular ma trix in acute viral hepatitis. Heoatology 12:249-256, 1990

• 12) Bucher, N. L. R., Robinson, G. S., Farmer, S. R.:Effects of extracellular matrix on hepatocyte growth and gene expression:Implications for hepatic regeneration and the repair of liver injury. Seminars in Liver Disease 10:11-19, 1990

• 13) Itoh, H., Takahara, T., Nakayama, Y. et al.:Immunoelectron microscopic observation of type IV collagen, laminin and heparan sulphate proteoglycan in capillarization of the sinusoid. J. Clin. Electron. Microscopy 23:668-669, 1990

• 14) Inuzuka, S., Ueno, T., Torimura, T. et al.:Vitronectin in liver disorders:biochemical and immunohistochemical studies. Hepatology 15:629-636, 1992
  pubmed

• 15) 小出典男:肝の細胞外マトリックスと疾患. Connective Tissue 25:213-218, 1993
  Medical*Online

• 16) Ueno, T., Inuzuka, S., Torimura, T. et al.:Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 105:475-481, 1993
  pubmed

• 17) Chojkier, M., Lyche, K. D., Filip, M.:Increased production of collagen in vivo by hepatocytes and nonparenchymal cells in rats with carbon tetrachloride induced hepatic fibrosis. 8:808-814, 1988
  pubmed

• 18) Friedman, S. L.:Cellular sources of collagen and regulation of collagen production in liver. Seminars in Liver Disease 10:20-29, 1990
  pubmed

• 19) Schuppan, D., Herbst, H., Milani, S.:Matrix, matrix synthesis, and molecular networks in hepaticfibrosis. In Extracellular Matrix. (Zern, M. A., Reid, LM. eds.), Marcel Dekker, New York, 1993 p.201-254

• 20) Nakatsukasa, H., Nagy, P., Evarts, R. P. et al.:Cellular distribution of transforming growth factor β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 85:1833-1843, 1990

• 21) Takahara, T., Sollberg, S., Muona, P. et al.:Type VI collagen gene expression in experimental liver fibrosis:Quantitation and spatial distribution of mRNAs, and immunodetection of the protein. Liver (in press)

• 22) Nouchi, T., Tanaka, Y., Tsukada, T. et al.:Appearance of α-smooth-muscle-actin positive cells in hepatic fibrosis. Liver 11:100-105, 1991

• 23) Yokoi, Y., Namihisa, T., Kuroda, H. et al.:Immunocytochemical detection of desmin in fat-storing cell (Ito cells) . J Hepatology 4:709-714, 1984

• 24) Weiner, F. R., Blaner, W. S., Czaja, M. J. et al.:Ito cell expression of a nuclear retinoic acid receptor. Hepatology 15:336-342, 1992
  pubmed

• 25) Nakatsukasa, H., Evarts, R. P., Hsia, C. C. et al.:Transforming growth factor-β1 and type I pro:collagen transcripts during regeneration and early fibrosis of rat liver. Lab. Invest. 63:171-180, 1990

• 26) Casini, A., Cunningham, M., Rojkind, M. et al.:Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13:758-765, 1991
  pubmed

• 27) Moshage, H., Casini, A., Lieber, C. S.:Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 12:511-518, 1990

• 28) Pares, A., Potter, J. J., Rennie, L. et al.:Acetaldehyde activates the promoter of the mouse α2 (1) collagen gene. Hepatology 19:498-503, 1994

• 29) 早川太郎:細胞外マトリックスの分解とその調節. 細胞外マトリックスのバイオサイエンスとバイオテクノロジー (藤本大三郎編), アイピーシー, 東京, 1991, p. 192-219

• 30) 岡崎勲, 荒井正夫, 和田則仁ほか:肝線維化過程におけるコラゲナーゼ, コラゲナーゼインヒビターの遺伝子発現の動態. 日本臨牀 51:428-434, 1993
  Medical*Online

• 31) 岡崎勲, 荒井正夫, 吉田貴彦ほか:肝線維化に関わる遺伝子. 肝胆膵 28:69-80, 1994

• 32) 岡田保典:マトリックスメタロプロテイナーゼの活性調節. 実験医学 10:256-262, 1992

• 33) Maruyama, K., Feinman, L., Fainsilber, Z. et al.:Mammalian collagenase increases in early alco holic liver disease and decreases with cirrhosis. Life Sci. 30:1379-1384, 1982

• 34) Perez-Tamayo, R., Montfort, I., Gonzalez, E.:Collagenolytic activity in experimental cirrhosis of the liver. Exp. Mol. Pathol. 47:300-308, 1987
  pubmed

• 35) Liotta, L. A., Abe, S., Gehron-Robey, P. et al.:Preferential digestion of basement membrane colla gen by an enzyme derived from a metastatic murine tumour. Proc. Natl Acad. Sci. USA 76:2268-2272, 1979

• 36) Arthur, M. J. P., Friedman, S. L., Roll, F. J. et al.:Lipocytes from normal rat liver release neutral metalloproteinase that degrades basement membrane (type IV) collagen. J. Clin. Invest. 84:1076-1085, 1989

• 37) Fujiwara, K., Sakai, T., Oda, T. et al.:The presence of collagenase in Kupffer cells of the rat liver. Biochem.,Biophys. Res. Commun. 54:531-536, 1973
  pubmed

• 38) Overall, C. M., Wrana, J. L, Sodek, J.:Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol Chem. 264:1860-1869, 1989

• 39) Herbst, H., Heinrichs, O., Schuppan, D. et al.:Temporal and spatial patterns of transin/strome:lysin expression following toxic injury in rat liver. Virchows Arch. B 60:295-300, 1991

• 40) Hayakawa, T., Yamashita, K., Ohuchi, E. et al.:Cell growth-promoting activity of TIMPs andtumor cell proliferation. The 41st Meeting of the Japanese Matrix Club, 1994, p. 48

• 41) 市田隆文, 井上恭一, 宮際幹ほか:肝疾患におけるコラゲナーゼインヒビターの臨床的意義. 肝臓 29:410, 1988

• 42) Murawaki, Y., Koda, M., Yamada, S. et al.:Serum collagenase activity in patients with chronicliver disease. J. Hepatol. 18:328-334, 1993

• 43) Li, J., Rosman, A, S., Leo M. A. et al.:Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19:1418-1423, 1994

• 44) Fukuda, Y., Imoto, M., Koyama, Y. et al.:Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol. Jpn. 26:37-41, 1991

• 45) Iredale, J. P., Murphy, G., Hembry, R. M. et al.:Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 90:282-287, 1992
  pubmed

• 46) Roeb, E., Graeve, L., Hoffmann, R. et al.:Regulastion of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18:1437-1442, 1993
  pubmed

• 47) 高原照美, 伊藤博行, 中山義秀ほか:肝線維化過程におけるコラゲナーゼとTIMP-1の遺伝子発現動態. 肝臓 33:733, 1992

• 48) Martinez-Hernandez, A., Delgado, F. M., Amenta, P. S.:The extracellular matrix in hepatic regeneration. Localization of collagen types I, III, IV, Laminin, and fibronectin.,Lab. In vest. 64:157-166, 1991

chapter3 サイトカイン

P.138 掲載の参考文献

• 1) Coley, W. B.:The treatment of malignant tumors by repeated inoculations of erysipelas:with a report of ten original cases. Am. J. Med. Sci. 105:487-511, 1893

• 2) Old, LJ.:Tumor necrosis factor (TNF) . Science 230:630-632, 1986

• 3) Balkwill, F. R.:腫瘍壊死因子とリンホトキシン. サイトカインとがん治療. (渡辺好彦 訳), 東京化学同人, 東京, 1991, p.59-95

• 4) Carswell, E. A., Old, L. J., Kassel, R. J. et al.:An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl.,Acad. Sci. USA 72:3666-3670, 1975

• 5) Loetscher, T. J., Yu-Ching, E. P., Hans-Werner, L. et al.:Molecular cloning and expression of the human 55 Kd tumor necrosis factor receptor. Cell 61:351-359, 1990

• 6) Schall, T. J., Lewis, M., Koller, K. J. et al.:Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370, 1990
  pubmed

• 7) Smith, C. A., Davis, T., Anderson, D. et al.:Areceptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023, 1990

• 8) Ruddle, N. H.:Lymphotoxin redux. Immunol. Today 6:156-159, 1985
  pubmed

• 9) 東伸昭:腫瘍壊死因子, リンホトキシン. 日本臨牀 50:1939-1944, 1992
  Medical*Online

• 10) 武田健, 巌本三寿, 竹田稔:TNFとリンフォトキシン. 医学のあゆみ別冊 サイトカイン. (今西二郎, 淀井淳司 編) 医歯薬出版, 東京, 1993, p.66-70

• 11) Jones, E. Y., Stuart, D. I., Walker, N. P. C. et al.:Structure of tumor necrosis factor. Nature 338:225-228, 1989

• 12) Eck, M. J., Ultsch, M., Rinderknecht, E. et al.:The structure of human lymphotoxin (tumor necrosis factor-beta) at 1. 9-A resolution. J. Biol. Chem. 267:2119-2122, 1992
  pubmed

• 13) Itoh, N., Yonehara, S., Ishii, A. et al.:The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apotosis. Cell 66:233-243, 1991

• 14) 米原伸:Fas抗原とTNFレセプター. 実験医学 17:2348-2353, 1993
  Medical*Online

• 15) Muto, Y., Nouri-Aria, K. T., Meager, A. et al,:Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet ii:72-74, 1988

• 16) Andus, T., Bauer, J., Gerok, W.:Effects of cytokines on the liver. Hepatology 13:364-375, 1991
  pubmed

• 17) Yoshioka, K., Kakumu, S., Arao, M. et al.:Tumor necrosis factor alpha production by peripheral mononuclear cells of patients with chronic Liver disease. Hepatology 10:769-773, 1989
  pubmed

• 18) Sheron, N., Lau, J., Daniels, H. et al.:Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J. Hepatol. 12:241-245, 1991
  pubmed

• 19) Tilg, H., Wilmer, A., Vogel, W. et al.:Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
  pubmed

• 20) Byl, B., Roucloux, I., Crusiaux, A. et al.:Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 104:1492-1497, 1993
  pubmed

• 21) Spengler, U., Moller, A., Jung, M. C. et al.:Tlymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-gamma upon mitogen stimulation. J. Hepatol. 15:129-135, 1992

• 22) Miller, L. C., Kaplan, M. M.:Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis:decrease by colchicine and relationship to HLA-DR 4. Am. J. Gastroenterol. 87:465-470, 1992
  pubmed

• 23) Khoruts, A., Stahnke, L, McClain, C. J. et al.:Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholics. Hepatology 13:255-259, 1991

• 24) Goto, M., Takei, Y., Kawano, S. et al:Tumor necrosis factor and endotoxin in the pathogenesis ofliver and pulmonary injury after orthotopic liver transplantation in the rat. Hepatology 16:487-493, 1992

• 25) Chazouilleres, O., Guechot, J., Balladur, P. et al.:Tumor necrosis factor-alpha in liver transplantation and resection. No evidence for a key role in ischemia-reperfusion injury. J. Hepatol. 16:376-379, 1992
  pubmed

• 26) Volpes, R., van-den-Oord, J. J., De-Vos, R. et al.:Hepatic expression of type A and type B receptors for tumor necrosis factor. J. J Hepatol. 14:361-369, 1992

• 27) Shedlofsky, S. I., McClain, C. J.:Hepatic dysfunction due to cytokines. Cytokines and Inflammation (Kimball, E. S. eds.), CRC Press, Boca Raton, FL, 1991, p. 235-275

• 28) Nagakawa, J., Hishinuma, I., Hirota, K. et al:Involvement of tumor necrosis factor alpha in the pathogenesis of activated macrophage-mediated hepatitis. Gastroenterology 99:758-765, 1990
  pubmed

• 29) Luster, M. I., Germolec, D. R., Yoshida, T. et al.:Endotoxin-induced cytokine gene expression and excretion in the liver. J Hepatology 19:480-488, 1994

• 30) Hoffmann, R., Grewe, M., Estler, H. C. et al.:Regulation of tumor necrosis factor-α-mRNA synnthesis and distribution of tumor necrosis factor-α-mRNA synthesizing cells in rat liver during experimental endotoxemia. J. Hepato 1. 20:122-128, 1994

• 31) Reinstein, LJ., Lichtman, S. N., Currin, R. T. et al.:Suppression of lipopolysaccharide-stimulated release of tumor necrosis faotor by adenosine:evidence for A 2 receptors on rat kupffer cells. Hepatology 19:1445-1452, 1994

• 32) Grewe, M., Gausling, R., Gyufko, K. et al.:Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages. J. Hepatol. 20:811-818, 1994

• 33) Lichtman, S. N., Wang, J., Schwab, J. H. et al.:Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology 19:1013-1022, 1994

• 34) Honchel, R., Marsano, L., Cohen, D. et al.:Lead enhances lipopolysaccharide and tumor necrosis factor liver injury. J. Lab. Clin. Med. 117:202-208, 1991
  pubmed

• 35) Bachem, M. G., Sell, K. M., Melchior, R. et al.:Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows,4 rch. B Cell Pathol. 63:123-130, 1993

• 36) Akerman, P., Cote, P., Yang, S. Q. et al.:Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263:G579-G 585, 1992

• 37) Pacitti, A. J., Inoue, Y., Souba, W. W.:Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver. J. Clin. Invest. 91:474-483, 1993

• 38) Beylot, M., Vidal, H., Mithieux, G. et al.:Inhibition of hepatic ketogenesis by tumor necrosis factor-alpha in rats. Am. J. Physiol. 263:E897-E 902, 1992

• 39) Beier, K., Volkl, A., Fahimi, H. D.:Suppression of peroxisomal lipid beta-oxidation enzymes of TNF-alpha. FEBS Lett. 310:273-276, 1992
  pubmed

• 40) Marino, M. W., Feld, LJ., Jaffe, E. A. et al.:Phosphorylation of the proto-oncogene product eukaryotic initiation factor 4 E is a common cellular response to tumor necrosis factor. J. Biol. Chem. 266:2685-2688, 1991

• 41) Wong, G. H. W., Elwell, J. H., Oberley, LW. et al.:Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931, 1989

• 42) Morita, M., Watanabe, Y., Akaike, T.:Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19:426-431, 1994

• 43) Ohira, H., Ueno, T., Shakado, S. et al.:Cultured rat hepatic sinusoidal endothelial cells express intercellular adhesion molecule-1 (ICAM-1) by tumor necrosis factor-α or interleukin-1 α stimulation. J. Hepatol. 20:729-734, 1994

• 44) Spitzer, J. A.:Cytokine stimulation of nitric oxide formation and differential regulation in hepato-cytes and nonparenchymal cells of endotoxemic rats. Hepatology 19:217-228, 1994

• 45) Van Ostade, X., Vandenabeele, P., Everaerdt, B. et al.:Human TNF mutants with selective activity on the p 55 receptor. Nature 361:266-269, 1993

• 46) Maeda, M., Watanabe, N., Yamauchi, N. et al.:Successful treatment of a case of hepatocellular carcinoma with tumor necrosis factor and local hyperthermia. Gastroenterologia Jpn. 26:774-778, 1991

• 47) Blankenstein, T., Qin, Z., Uberla, K. et al:Tumor cell targeted cytokine (TNF-α) gene therapy for cancer. Immunol. Today 11:4341, 1990

P.148 掲載の参考文献

• 1) Thomas, K. A., Gimenzo-Gallego, G.:Fibroblast growth factors:broad spectrum mitogens with Potent angiogenic activity. Trends Biochem. Sci. 11:81-84, 1986

• 2) Buckley-Sturrock, A., Woodward, S. C., Senior, R. M. et al.:Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound rapair tissues and human skin by growth factors. J. Cell Physiol. 138:70-78, 1989

• 3) Godspodarowicz, D.:Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249:123-127, 1974
  pubmed

• 4) Abraham, J. A., Mergia, A., Whang, J. L. et al.:Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548, 1986
  pubmed

• 5) Lobb, R. R., Wade Happer, J., Fett, J. W.:Purification of heparin-binding growth factors. Anal. Biochem. 154:1-14, 1986

• 6) Klagsbrum, M.:The fibroblast growth factor family:structural and biological properties. Prog. Growth Factor I〜es. 1:207-235, 1989

• 7) Rifkin, D. B., Moscatelli, D.:Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1-6, 1989
  pubmed

• 8) Hoffmann, B., Paul, D.:Basic fibroblast growth factor and transforming growth factor-α are hepatotrophic mitogens in vitro. J. Cell. Physiol. 142:149-154, 1990

• 9) Massimo, P., Hanna, E. A., Loreto, G.:Regulation of macrophage colony stimulating factor in liver fat-storing cells by peptide growth factors. Am.,, I. Physiol. 262 (Cell Physiol. 31):C876-C881, 1992

• 10) Yoshitake, Y., Nishikawa, K.:Distribution of fibroblast growth factors in cultured tumor cells and their transplants. In Vitro Cell Dev. Biol. 28 A:419-428, 1992

• 11) Matsuzaki, K., Yoshitake, Y., Miyagiwa, M. et al.:Production of basic fibroblast growth factor like factor by cultured human cholangiocellular carcinoma cells. Jpn. J. Cancer Res.81:345-354, 1990
  pubmed

• 12) Yamamoto, N., Matsunami, S., Yoshitake, Y. et al.:Immunohistochemical localization of basic fibroblast growth factor in A431 human epidermoid carcinoma cells. Histochemistry 96:479-485, 1991

• 13) Shiurba, R. A., Jing, N., Sakakura, T. et al.:Nuclear translocation of basic fibroblast growth factor during Xenopus mesoderm induction. 1) evelopment 113:487-493, 1991

• 14) Kan, M., Yan, G. C., Xu, J.:Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF) . In Vitro Cell Dev. Biol. 28 A:515-520, 1992

• 15) 三井洋司, 今村享:FGFと新規ECGFによる血管系細胞の増殖抑制:蛋白質 核酸 酵素 臨時増刊-細胞増殖因子の基礎と臨床. 36:1237-1246, 1991

• 16) Satoh, H., Shino, A., Sato, F. et al.:Role of endogenous and exogenous bFGF in the healing of gastric ulcers in the rat. Gastroenterology 102:A159, 1992

• 17) Halaban, R., Kwon, B. S., Ghosh, S. et al.:bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3:177-186, 1988
  pubmed

• 18) Zongyi, H., Evarts, R. P., Fujio, K. et al.:Expression of transforming-alpha/epidermal growth factor receptor, hepatocyte growth factor/C-met, acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Hepatology 18:160 A, 1993

• 19) Yoshitake, Y., Nishikawa, K:Distribution of fibroblast growth factors in transplants. In Vitro Cell Dev. Biol. 29 A:419-423, 1992

• 20) Watanabe, A., Miyazaki, M., Taketa, K.:Differential mechanisms of increased α1-fetoprotein pro duction in rats following carbon tetrachloride injury and partial hepatectomy. Cancer Res. 36:2171-2175, 1976

• 21) Rosenbaum, J., Blazejewski, S., Mallat, A. et al.:Fibroblast growth factor 2 (FGF 2) mediates transforming growth factor β1 (TGFβ1) mitogenic effect for human cells. Hepatology 18:168 A, 1993

• 22) Marsden, R. E., Hu, Z., Fujio, K. et al.:Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab. Invest. 67:427-433, 1992

• 23) Motoo, Y., Sawabu, N., Yamaguchi, Y. et al.:Sinusoidal capillarization of human hepatocellular carcinoma:possible promotion by fibroblast growth factor. Oncology 50:270-274, 1993
  pubmed

• 24) Lee, D. H., Lee, S. H., Yoo, Y. G. et al.:Elevation of angiogenic, basic fibroblast growth factor, and epidermal growth factor in sera of the patients with hepatocellular carcinoma after transcathe-ter arterial embolization. Gastroenterology 106:A926, 1994

P.160 掲載の参考文献

• 1) Gery, 1., Gershon, R. K., Waksman, B. H.:Potentiation of the T-lymphocyte response to mitogens. 1. The responding cell. J. Exp. Med. 136:128-142, 1972

• 2) Rosenwasser, L J., Dinarello, C. A., Rosenthal, A. S.:Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic Pyrogen. J. Exp. Med. 150:709-714, 1979
  pubmed

• 3) Wood, D. D.:Purification and properties of human B cell-activation factor. J. Immunol. 123:2395-2399, 1979

• 4) Lomedico, P. T., Gubler, U., Hellmann, C. P. et al:Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458-462, 1984
  pubmed

• 5) Auron, P. E., Webb, A. C., Rosenwasser, L. J. et al.:Nucleotide sequence of human monocyte in terleukin l precursor cDNA. Proc. Natl. Acad. Sci. USA 81:7907-7911, 1984

• 6) March, C. J., Mosley, B., Larsen, A. et al.:Cloning, sequence and expression of two distinct humaninterleukin-1 complementary DNAs. Nature 315:641-647, 1985

• 7) Besedovsky, H., del Ray, A., Sorkin, E. et al.:Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654, 1986

• 8) Durum, S. K., Schmidt, J. A., Oppenheim, J. J.:Interleukin 1:an immunological perspective. Ann. Rev. Immunol. 3:263-287, 1985

• 9) Oppenheim, J., Kovacs, E., Matsushima, K. et al.:There is more than one interleukin-1. Immunol. Today 7:45-56, 1986
  pubmed

• 10) Dinarello, C. A.:Interleukin-1.,Rev. Infect. Dis. 6:51-95, 1984
  pubmed

• 11) Beuscher, H. U., Fallon, R. J., Colten, H. R.:Macrophage membrane interleukin l regulates the expression of acute phase proteins in human Hep 3B cells. J. Immunol. 139:1896-1901, 1987

• 12) Ghezzi, P., Saccardo, B., Villa, P. et al.:Role of interleukin-1 in the depression of liver drug metabolism by endotoxin.,lnfect. immunol. 54:837-840, 1986

• 13) Bertini, R., Bianchi, M., Erroi, A. et al.:Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serumiron. J. Leucocyte J Biol. 46:254-262, 1989

• 14) Fibbe, W. E., Van Damme, J., Billiau, A. et al.:Interleukin l induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colonystimulating factor. Blood 71:430-435, 1988

• 15) Onozaki, K., Matsushima, K., Aggarwal, B. B. et al.:Human interleukin l is a cytocidal factor forseveral tumor cell lines. J. Immunol. 135:3962-3968, 1985

• 16) Hirano, T., Yasukawa, K., Harada, H. et al.:Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73-76, 1986
  pubmed

• 17) Van Damme, J., Opdenakker, G., Simpson, R. J. et al.:Identification of the human 26-kD protein, interferon b 2 (IFN-b 2), as a B cell hybridoma/plasmacytoma growth factor induced by inter-leukin l and tumor necrosis factor. J. Exp. Med. 165:914-919, 1987

• 18) Kishimoto, T.:The biology of interleukin-6. Blood 74:1-10, 1989
  pubmed

• 19) Gauldie, J., Richards, C., Harnish, D. et al.:Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251-7255, 1987
  pubmed

• 20) Andus, T., Geiger, T., Hirano, T. et al:Recombinant human B cell stimulatory factor 2 (BSF-2/ IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221:18-22, 1987

• 21) Kobune, M., Kohgo, Y., Kato, J. et al.:Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 19:1468-1475, 1994

• 22) Yoshimura, T., Matsushima, K., Tanaka, S. et al.:Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84:9233-9237, 1987

• 23) Matsushima, K., Morishita, K., Yoshimura, T. et al.:Molecular cloning of a human monocyte-de-rived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin l and tumor necrosis factor. J. Exp. Med. 167:1883-1893, 1988

• 24) Strieter, R. M., Kunkel, S. L, Showell, H. J. et al.:Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243:1467-1469, 1989

• 25) Strieter, R. M., Phan, S. H., Showell, H. J. et al.:Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J. Biol Chem. 264:10621-10627, 1989
  pubmed

• 26) Herberman, R. B., Ortaldo, J. R.:Natural killer cells. Science 214:24-30, 1981
  pubmed

• 27) Melder, R. J., Walker, E., Herberman, R. B. et al.:Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell. Immunol 132:177-192, 1991
  pubmed

• 28) Melder, R. J., Whiteside, T. L, Vujanovic, N. L. et al.:Anew approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res. 48:3461-3469, 1988

• 29) Wright, S. C., Bonavida, B.:Studies on the mechanism of natural killer cell-mediated cytotoxicity. 1. Release of cytotoxic factors specific for NK-sensitive target cells during co-culture of NK effector cells with NK target cells. J. Immunol 129:433-439, 1982

• 30) Hata, K., Thiel, D. H., Herberman, R. B. et al.:Natural killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 14:495-503, 1991
  pubmed

• 31) Vanderkerken, K., Bouwens, L., Kuppen, P. et al.:Effect of irradiation hepatic natural killer cells. Hepatology 19:1453-1458, 1994

• 32) Grimm, E. A., Mazumder, A., Zhang, H. Z. et al.:Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823-1841, 1982
  pubmed

• 33) Damle, N. K., Doyle, L. V., Bradley, E. C.:Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors. J. Immunol. 137:2814-2822, 1986
  pubmed

• 34) Kakumu, S., Shinagawa, T., Ishikawa, T. et al.:Serum interleukin 6 levels in patients with chronic hepatitis B.Am.J. Gastroenterol. 86:1804-1808, 1991
  pubmed

• 35) Sun, Y., Tokushige, K., Isono, E. et al:Elevated serum interleukin-6 levels in patients with acute hepatitis. J. Clin.Immunol. 12:197-200, 1992
  pubmed

• 36) Sheron, N., Bird, G., Koskirias, J. et al:Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 18:41-46, 1993

• 37) Thornton, A. J., Strieter, R. M., Lindley, I. et al.:Cytokine-induced gene expression of a neutro-phil chemotactic factor/IL-8 in human hepatocytes. J. Immunol. 144:2609-2613, 1990

• 38) Shimizu, Y., Okada, K., Tsukishiro, T. et al.:Cytokine effect on the concentrations of interleukin-8 (IL-8) in the culture medium of human liver tumor cell lines.Int. Hepatol. Commun. 1:174-177, 1993

• 39) Okada, K., Shimizu, Y., Tsukishiro, T. et al.:Serum interleukin-8 levels in patients with hepatocellular carcinoma. Int. Hepatol. Commun. 2:178-182, 1994

• 40) Koch, A. E., Polverini, P. J., Kunkel, S. L. et al.:Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801, 1992
  pubmed

• 41) Guillou, P. J.:Potential impact of immunobiotechnology of cancer therapy. Br. J. Science. 74:705-710, 1987

• 42) Bindon, C., Czerniecki, M., Ruell, P. et al.:Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human sublects. Br. J. Cancer 47:123-133, 1983

• 43) Donohue, J. H., Rosenberg, S. A.:The fate of interleukin-2 after in vivo administration. J. Immunol. 130:2203-2208, 1983
  pubmed

• 44) Uchino, J., Une, Y., Kawata, A. et al.:Postoperative chemoimmunotherapy for the treatment of liver cancer. Semin. Surg. Oncol. 9:332-336, 1993
  pubmed

• 45) Komatsu, T., Yamauchi, K., Furukawa, T. et al.:Transcatheter arterial injection of autologous lymphokine-activated killer (LAK) cells into patients with liver cancers. J. Clin. Immunol. 10:167-174, 1990
  pubmed

• 46) Kawano, M., Hirano, T., Matsuda, T. et al.:Autocrine generation and requirement of BSF 2/IL-61 for human multiple myelomas. Nature 332:83-85, 1988

• 47) Miki, S., Iwano, M., Miki, Y. et al.:Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 250:607-610, 1989

• 48) Okada, K., Shimizu, Y., Nambu, S. et al.:Interleukin-6 functions as an autocrine growth factor in acholangiocarcinoma cell line. J. Gastroenterol. Hepatol. (in press)

P.173 掲載の参考文献

• 1) Isaacs, A., Rindenmann, J.:Virus Interference. I. The interferon. Proc. Roy. Soc. Ser. B. 147:258, 1957

• 2) Fish, E. N.:Definition of receptor binding domains in interferon-α. J. IFN Res. 12:257-266, 1992

• 3) Harada, H., Fujita, T., Miyamoto, M. et al.:Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739, 1989

• 4) Verazquez, L., Fellous, M., Stark, G. R. et al.:A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-322, 1992

• 5) Valente, G. L., Ozmen, L., Novelli, F. et al.:Distribution of interferon-y receptor in human tissues. Eur. J. immunol. 22:2403-2412, 1992

• 6) Moore, G., Gewert, D. R.:Inhibition of cell proliferation by interferons. II, changes in processing and stability of newly synthesized DNA in human lymphoblastoid (Daudi) cell Eur. J. Biochem. 139:619, 1984

• 7) 荒井澄夫, 桑田剛一:インターフェロンγと免疫グロブリンクラスの決定. 免疫臨床 23:1553, 1991

• 8) 市田文弘, 宮際幹ほか:IFN治療後に小柴胡湯を投与し HBe抗体へのseroconversionを認めたB型肝炎の1例. 難治症の漢方治療 (第5集), 現代東洋医学13 (1) 臨時増刊号:70, 1992

• 9) Tsubota, A., Chayama, K., Ikeda, K. et al.:Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094, 1994

chapter4 生理

P.188 掲載の参考文献

• 1) Hay, D. W., Carey, M. C.:Pathophysiology and pathogenesis of cholesterol gallstone formation. Semin. Liver Dis. 10:159-170, 1990
  pubmed

• 2) Wheeler, H. O., Ross, E. D., Bradley, S. E.:Canalicular bile production in dogs. Am. J. Physiol. 214:866-874, 1968
  pubmed

• 3) 木谷健一:いわゆる有機陰イオンによる浸透圧性利胆機構への疑問. 胆汁酸依存胆汁を中心として. 肝臓 21:1710-1712, 1980

• 4) Navak, D. A., Ryckman, F. C., Suchy, F. J.:Taurocholate transport by basolateral plasma membrane vesicles isolated from human liver. Hepatology 10:447-453, 1989

• 5) Sellinger, M., Barrett, C., Malle, P. et al.:Cryptic Na+, K+-ATPase activity in rat liver canalicular plasma membranes:evidence for its basolateral origin. Hepatology 11:223-229, 1990
  pubmed

• 6) Goeser, T., Nakata, R., Braly, L. F. et al.:The rat hepatocyte plasma membrane organic anion binding protein is immunologically related to the mitochondrial F l adenosine triphosphate beta-subunit. J. Clin. Invest. 86:220-227, 1990

• 7) Moseley, R. H., Morrissette, J., Johnson, T. R.:Transport of N1-methylnicotinamide by organic cation-protein exchange in rat liver membrane vesicles. Am. J. Physiol. 259:973-982, 1990

• 8) Isikawa, T., Muller, M., Klunemann, C. et al.:ATP-dependent primary active transport of crysteinyl leukotrienes across liver canalicular membrane. J. Biol. Chem. 265:19279-19286, 1990

• 9) 木谷健一:胆汁酸の輸送と胆汁生成. 肝臓 (木谷健一, 戸田剛太郎 編), 南光堂, 東京, 1990, p.43-57

• 10) Phillips, M. J., Oda, M., Mak, E. et al.:Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology 69:48-58, 1975
  pubmed

• 11) Gabbiani, G., Montesano, R., Tuchweber, B. et al.:Phalloidin-induced hyperplasia of actin filaments in rat hepatocytes. Lab. Invest. 33:562-569, 1975
  pubmed

• 12) Oshio, C., Phillips, M. J.:Contractility of bile canaliculi:implications for liver function. Science 212:1041〜1042, 1981

• 13) Phillips, M. J., Oshio, C., Miyairi, M. et al.:A study of bile canalicular contractions in isolated he patocytes:methods and time series analysis. Hepatology 2:777-783, 1982

• 14) Phillips, M. J., Oshio, C., Miyairi, M. et al.:Intrahepatic cholestasis as a canalicular motility disorder:evidence using cytochalasin. Lab. Invest. 48:205-211, 1983
  pubmed

• 15) Adelstein, R. S.:Calmodulin and the regulation of the actin-myosin interaction in smooth muscle and nonmuscle cells. Cell 30:341-345, 1982

• 16) Watanabe, S., Phillips, M. J.:Ca2+ causes active contraction of bile canaliculi:Direct evidence from microinjection studies. Proc. Natl. Acad. Sci. US.,481:6164-6168, 1984

• 17) 渡辺純夫, 判野昌厚, 竹内真ほか:肝細胞質カルシウムイオン濃度と毛細胆管収縮. 肝臓 28:922-925, 1987

• 18) Hardisson, W. G. M., Dalle-Molle, E., Gosink, E. et al.:Function of rat hepatocyte tight junctions:studies with bile acid infusions. Am. J. Physiol. 260:167-174, 1991

• 19) Bondesen, S., Christensen, H., Lindoff-Larsen, K. et al.:Plasma secretin in response to pure bile salts and endogenous bile in man. Dig. dis. Sci. 30:440-444, 1985

• 20) 吉武正男, 向坂彰太郎, 上野隆登ほか:肝内胆管上皮細胞におけるセクレチンの動態-光顕並びに電顕免疫組織化学法による観察-. 肝臓 29:215-221, 1988

• 21) Hayakawa, T., Bruck, R., Ng, O. C. et al.:Dibutynyl adenosine 3, 5:-cyclic monophosphate stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am. J. Physiol. 259:727-735, 1990

• 22) Hamlin, S., Rahman, K., Carrella, M. et al.:Modulation of biliary lipid secretion by forskolin and cyclic AMP analogues. Biochem. J. 265:879-885, 1990
  pubmed

• 23) Corasanti, J. G., Smith, N. D., Gordon, E. R. et al.:Protein kinase C agonists inhibit bile secretion independently of effects on the microcirculation in the isolated perfused rat liver. Hepatology 10:8-13, 1989
  pubmed

• 24) Myant, N. B.:The metabolism of cholesterol. The Biology of Cholesterol and Related Steroids, William Heineman Medical Books Ltd., London, 1981, p. 229-298

• 25) Radominska, A., Treat, S., Little, J.:Bile acid metabolism and the pathophysiology of cholestasis. Sem in. L iver Dis. 13:219-234, 1993

• 26) Sachy, F. J.:Hepatocellular transport of bile acids. Semin. Liver Dis. 13:235-247, 1993

• 27) Arias, I. M.:The biology of hepatic endothelial cell fenestrate. Prog. Liver Dis. 9:11-26, 1990

• 28) LaRusso, N. F., Korman, M. G., Hoffmann N. E. et al.:Dynamics of the enterohepatic circulation of bile acids. N. Engl. J. Med. 291:689-692, 1974

• 29) 松崎靖司, 飯塚儀明, 田中直見ほか:胆汁酸. 綜合臨牀 40 (増刊):1394-1397, 1991

• 30) Mizoguchi, Y., Ohnishi, F., Monna, F. et al.:Studies on intrahepatic cholestasis in drug induced allergic hepatitis:intrahepatic cholestasis induced in rat by culture supernatant of activated lymphocytes. Hepatogastroenterology 28:147-150, 1981

• 31) 大菅俊明, 本多彰, 吉田正:胆石の生成と分類. 最新内科学体系52胆石, 胆道癌 (山村雄一, 吉利和監), 中山書店, 東京, 1992, p.147-166

• 32) Strasberg, S. M., Harvey, P. R. C.:Biliary cholesterol transport and precipitation:introduction and overview of conference. Hepatology (Suppl.) 12:S1-S 5, 1990

• 33) Hill, M. J., Crowther, J. S., Drasar, B. S. et al.:Bacteria and aetiology of cancer of large bowel. Lancet 1:95-100, 1971
  pubmed

• 34) Murray, W. R., Blackwood, A., Trotter, J. M. et al.:Faecal bile acids and clostridia in aetigology of colorectal cancer. Br. J. Cancer 41:923-928, 1980

• 35) 石本喜和男, 勝見正治, 津秦健治ほか:大腸癌における糞便中胆汁酸分画の測定-健常人と比較して. 日外会誌 85:375, 1984

• 36) Schmid, R., McDonagh, A. F.:Hyperbilirubinemia. The Metabolic Basis of Inherited Disease (Stanbury, J. B., Wyngaarden, J. B., Fredrick, D. S. eds.), McGraw-Hill, 4th ed, 1990, p. 1221-1257

• 37) Kino, K., Tsunoo, H., Higa, Y. et al.:Hemoglobin-haptoglobin receptor in rat liver plasma membrane. J. Biol. Chem. 255:9616-9620, 1980
  pubmed

• 38) Kino, K., Tsunoo, H., Higa, Y. et al.:Kinetic aspects of hemoglobinhaptoglobin-receptor interaction in rat liver plasma membranes, isolated liver cells, and liver cells in primary culture. J.,Biol. Chem. 257:4828-4833, 1982

• 39) Muller-Eberhald, U., Bosman, C., Liem, H. H.:Tissue localization of the heme-hemopexin complex in the rabbit and the rat as studied by light microscopy with the use of radioisotopes. J. Lab. Clin. Med. 76:426-431, 1970

• 40) Nakajima, H.:Studies on heme α-methenyl oxygenase II. The isolation and characterization of the final reaction product, a possible precursor of biliverdin. J. Biol. Chem. 238:3797-3801, 1963

• 41) Yoshida, T., Kikuchi, G.:Features of the reaction of heme degradation catalyzed by the reconstituted microsomal heme oxygenase system. J. Biol. Chem. 253:4230-4236, 1978
  pubmed

• 42) Brodersen, R.:Binding of bilirubin to albumin. CRC. Crit. Rev. Clin. Lab. Sci. 11:305-399, 1980
  pubmed

• 43) Tiribelli, C., Ostrow, J. D.:New concepts in bilirubin chemistry, transport and metabolism:report of the second international bilirubin workshop, april 9-11, 1992, Trieste, Italy. Hepatology 17:715-736, 1993
  pubmed

• 44) Kamisaka, K., Listowsky, I., Gatmaitan, Z. et al.:Interaction of bilirubin and other ligands with ligandin. Biochemistry 14:2175-2179, 1975
  pubmed

• 45) Chowdhury, J. R., Wolkoff, A. W., Arias, I. M.:Heme and bile pigment metabolism. The Liver:Biology and Pathobiology (Irwin, M., Arias, I. M., William, B. et al. eds.), Raven Press, New York, 1988, p. 419-449

• 46) Billing, B. H.:Intestinal and renal metabolism of bilirubin including enterohepatic circulation. Bile Pigments and Jaundice (Ostrow J. D. eds.), Merel Dekker Inc., New York and Basel, 1986, p. 225-269

• 47) Pimstone, N. R., Engel, P., Tenhunen, R. et al.:The enzymatic degradation of hemoglobin to bile pigments by macrophages. J. Exp. Med. 133:1264-1281, 1971

• 48) Adachi, Y., Inofusa, H., Yamashita, M. et al.:Human serum bilirubin fractionation in various hepatobiliary diseases by the newly developed high-performanced liquid chromatography. Gastroenterol. Jpn. 23:268-272, 1988

• 49) Sato, H., Koiwai, O., Tanabe, K. et al:Isolation and sequencing of rat liver bilirubin UDP-glucuronosyl-transferase cDNA:Possible alternate splicing of a common primary transcript. Biochem. Biophys. Res. Commun. 169:260-264, 1990

• 50) Sharschmidt, B. F., Blanckaert, N, Farina, F. A. et al.:Measurement of serum bilirubin and its mono-and diconjugates:application to patients with hepatobiliary disease. Gut 23:643-649, 1982

• 51) 山本俊夫:デルタビリルビンについて. 第3回肝代謝研究会報告集, 1986, p.133-143

P.203 掲載の参考文献

• 1) 藤田尚男, 藤田恒夫:標準組織学各論, 第3版, 医学書院, 東京, 1993, p.149-169

• 2) 土屋雅春, 織田正也, 塚田信廣:肝臓の毛細血管-類洞の特性とその異常-. 細胞 17:12-17, 1985

• 3) 金子丑之助:日本人体解剖学, 第18版, 南山堂, 東京, 1992, p.99-110

• 4) 芝山雄老, 中田勝次:臨床生理学シリーズ5肝臓 (木谷健一ほか編), 南江堂, 東京, 1990, p.2-10

• 5) Oda, M., Tsukada, N., Watanabe, N. et al.:Heterogeneity of hepatic lobule-some ultrastructural aspects of hepatic microcirculation system-. J. Clin. Electron Mic roscopy 16:5-6, 1983

• 6) McCuskey, R. S.:Adynamic and static study of hepatic arterioles and hepatic sphincters. Am. J. Anat. 119:455-478, 1966

• 7) Burkel, W. E.:The find structure of the terminal branches of the hepatic arterial system of the rat. Anat. Rec. 167:329-350, 1970

• 8) 織田正也, 塚田信廣, 渡辺勲史ほか:肝微小循環の調節機構-生体顕微鏡ならびに超微形態学的立場から-. 脈管学 24:33-44, 1984

• 9) 織田正也, 塚田信廣, 小松弘一ほか:肝類洞内皮細胞の超微形態と機能. 肝臓 24:1639-1643, 1984

• 10) 藤城保男, 土屋雅春:肝循環の自動調節. 血液と脈管 3:917-925, 1972

• 11) 芝山雄老, 常田実, 斉藤雅文ほか:胃癌術後に生じた広範な肝梗塞-四剖検例についての検討-. 肝臓 22:1285-1292, 1981

• 12) 芝山雄老, 松本和基, 斉藤雅文ほか:肝細胞の空胞変成の発生機序-類洞圧上昇の原因的意義-. 肝臓 21:1283-1294, 1980

• 13) Takano, A., Shibayama, Y., Nakata, K.:The morphogenesis of the vacuolation of liver cells. Liver 4:97-104, 1984
  pubmed

• 14) Ohnishi, K., Takatsune N., Koen H.:Interrelationship between type of portal systemic shunt and portal vein pressure in patients with liver disease. Am. J. Gastroenterol. 80:561-564, 1985

• 15) 芝山雄老, 中田勝次:臨床生理学シリーズ5肝臓 (木谷健一ほか編), 南江堂, 東京, 1990, p.17-25

• 16) 木谷健一:門脈圧亢進症-私の考え方. 肝胆膵 22:581-587, 1991

• 17) 今井深, 亀田治男:特発性門脈圧亢進症. 肝胆膵 22:519-527, 1991

• 18) 高安幸生, 中尾宣夫, 三浦行:門脈圧亢進症の血管造影診断. 画像診断 13:1350-1356, 1993

• 19) 山下俊一, 中田恵輔, 室豊吉ほか:肝内びまん性門脈-肝静脈短絡による猪瀬型肝性脳症の1例. 日内会誌 71:844-850, 1982

• 20) Acharya, S. K., Dasarathy, S., Saksena, S. et al.:Aprospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J. Hepatol. 19:291-300, 1993

• 21) Bosch, J., Garcia-Pagan, J. C., Feu, F. et al.:New approaches in the pharmacologic treatment of portal hypertension. J. Hepatol. 17 (Suppl. 2):S41-S45, 1993

• 22) Lin, C. Y., Lin, P. W., Tsai, H. M. et al.:Influence of paraesophageal venous collaterals on efficacy of endoscopic sclerotherapy for esophageal varices. Hepatology 19:602-608, 1994

• 23) 児島邦明, 二川俊二:食道胃静脈瘤の治療. 外科手術. 肝胆膵 28:389-398, 1994

• 24) Sarfeh, I. J., Rypins, E. B., Mason, G. R.:Asystematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann. Surg. 204:356-363, 1986

• 25) 松室健士, 梅原藤雄, 北島動ほか:先天性肝外門脈大循環短絡による肝性脳症. 臨床神経学 28:133-136, 1988

• 26) Rosch, J., Hanafee, W. N, Snow, H.:Working in progress. Transjugular portal venography and radiologic portacaval shunt. An experimental study. Radiology 92:1112-1114, 1969

• 27) Colapinto, R. F., Stronell, T. D., Birch, S. J. et al.:Creation of an Gruntzig balloon catheter. Can. Med. Assoc. J. 126:267-268, 1982

• 28) Richter, G. M., Palmaz, J. C., Noldge, G. et al.:Der transjugulare intrahepatische portosystemische Stent-Shunt (TIPSS) . Radiology 29:406, 1989
  pubmed

• 29) 山田龍作, 佐藤守男, 岸和史ほか:経皮的肝内門脈静脈短絡術 (TIPS) の経験. 日本医放会誌 52:1328-1330, 1992

• 30) 塩山靖和, 山田龍作:門脈圧亢進に対するInterventional Radiology-TIPSを中心に-. 画像診断 13:1383-1391, 1993

• 31) Sanyal, A. J., Freedmann, A. M., Shiffman, M. L. et al.:Protosystemic encephalopathy after transjugular intrahepatic portosystemic shunt:result of a prospective controlled study. Hepatology 20:46-55, 1994

• 32) Azouulay, D., Castaing, D., Dennison, A. et al.:Transjugular intrahepatic portosystemic shunt worsens the hyper dynamic circulatory state of the cirrhotic patients:Preliminary report of a prospective study. Hepatology 19:129-132, 1994

• 33) Conn, H. O.:Transjugular intrahepatic portal-systemic shunts:The state of art. Hepatology 17:148-158, 1993
  pubmed

• 34) 樫田博史, 寺井裕二, 山本健二ほか:門脈-大循環分流術が著効を奏したPortasystemic Encephalopathyの一症例. JJPEN 16:248-250, 1994

P.215 掲載の参考文献

• 1) Hubbard, D., Lucas, D. L.:Ionic charges of glass surfaces and other materials, and their possible role in the coagulation blood. J. App I. Physiol. 15:265, 1960

• 2) Becker, C. G., Hamont, N. V., Wagner M. et al.:Tobacco, cocoa, coffee, and regweed:Cross reacting allergens that activate factor XII-dependent pathways. Blood 58:861-867, 1981

• 3) Didishim, P., Mibashan, R. S.:Activation of Hageman factor (factor XII) by long-chain saturated fatty acids. Th romb. Haemost. 9:346, 1963

• 4) Bithell, T. C.:Blood Coagulation. Wintrobe:s clinical haematology (Lee, G. R., Bithell, T. C., Forester, J. et al eds.), Lea & Febiger, Philadelphia, London, 1993, p. 566-615

• 5) 小山高敏, 青木延雄:凝固系の働き. medicina 30:6-9, 1993

• 6) Altieri, D. C., Morrisey, J. M., Edgington, T. S. et al:Adhesive recepter Mac-l coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation:an alternative initiation of coagulation protease cascade. Proc. Natl. Acad. Sci. USA 85:7462-7466, 1988

• 7) Broze, G. J. Jr., Girard, T. J., Novotny, W. F. et al.:Regulation of coagulation by multivalent Kunitztype inhibitor. Biochem is try 29:7539, 1990

• 8) 加藤久雄:リポ蛋白結合性プロテアーゼインヒビター. Annual Review 血液 1992 (高久文麿 編), 中外医学社, 東京, 1992, p.105

• 9) Rapaport, S. I.:The extrinsic pathway inhibitor:Aregulator of tissue factor-dependent blood coagulation. Thromb. Ilaemast. 66:6-15, 1991

• 10) Edgington, T. S., Mackman, N., Edgington, T. S. et al.:structual biology of expression and function of tissue factor. Th romb. Haemost. 66:67-79, 1991

• 11) Yu, LC., Malkani, I., Regueria, O. et al.:Recombinant tissue plasminogen activator (rt-PA) forveno-occlusive disease in pediatric autologous bone marrow transplant patients. Am. J. Hematol. 46:194-198, 1994

• 12) 小出武比古:ヘパリン依存性トロンビンインヒビター. 医学のあゆみ 160:599-603, 1992
  Medical*Online

• 13) van Mourik, J. A., Lawrence, D. A., Luskutoff, D. J. et al.:Purification of an inhibitor of plasminogen inhibit or synthesized by endothelial cells. J.,Biol. Chem. 259:14914-14921, 1984
  pubmed

• 14) Busso, N., Nicodeme, E., Chesne, C. et al.:Urokinase and type l plasminogen activator inhibitor production by normal human hepatocytes:modulation inflammatory agents. Hepatology 20:186-190, 1994

• 15) Hersch, S. L., Kunelis, T., Francis, R. B. et al.:The pathogenesis of accelerated of fibrinolysis in liver cirrhosis-A criteria role for tissue plasminogen activator inhibitor. Blood 69:1315-1319, 1987

• 16) Pernambuco, J. R., Langley, P. G., Hughes, R. D. et al:Activation of fibrinolytic system in patie. nts with fluminant liver failure. Hepatology 18:1350-1356, 1993

• 17) Violi, F., Fero, D., Basili, S. et al.:Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. Hepatology 17:78-83, 1993

• 18) Matsuno, K., Araki, K.:Anew:advance in theory of blood coagulation and fibrinolysis and its Practical application. Rinsyo-Byouri 39:179-184, 1991

• 19) Lipsy, J. J.:N-methyl-thio-tetorazole inhibition of the gamma carboxylation of glutamic acid possible mechanism for antibiotic-associated hypoprothrombinemia. Lancet 2:242-248, 1981

• 20) Liebman, H. A., Furie, B. C., Tong, M. J. et al.:Des-y-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 310:1427-1431, 1984

• 21) Okuda, H., Nakanishi, T., Furukawa, M. et al.:Vitamin K-dependent proteins and hepatocellular carcinoma. J. Gastroenterol. Hepatol. 6:392-399, 1991
  pubmed

• 22) Fujiyama, S., Izuno, K., Gohshi, K. et al.:Clinical usefullness of des-y-carboxyprothrombin as say in early diagnosis of hepatocellular carcinoma. Dig. Dis. Sci. 36:1787, 1991

• 23) 安島豊子:肝細胞癌の性状, 経過および予後からみたPIVKA-IIの臨床的意義. 東京女子医科大学雑誌 62:1019, 1992

• 24) Yosikawa, Y., Sakata, Y., Toda, G. et al.:The acquired vitamin K-dependent gamma-carboxyla tion deficiency in hapatocellular carcinoma involves not only prothrombin but protein C. Hepatology 8:524-530, 1988

• 25) Shah, D. V., Engeleke, J. A., Suttie, J. W. et al.:Abnormal prothrombin in the plasma of rats carrying hepatic tumors. Blood 69:850-854, 1987

• 26) Samama, M., Soria, J., Soria, C.:Congenital and acquired dysfibrinogenemia. Recent advance in blood coagulation (Poller, L. ed.), Churchill Livingstone, Edingburgh, London, New York, 1977, p. 313-335,

• 27) 青木延雄:DICの成因に関する調査結果. 厚生省特定疾患汎発性血管内凝固症調査研究班, 昭和54年度業績報告集, 1980, p.38

• 28) Cordova, C., Musca, A., Violi, F. et al.:Improvement some blood coagulation factors cirrhotic patients treated with low doses of heparin. Scand. J. Haematol. 29:235-240, 1982
  pubmed

• 29) 前川正:肝機能障害例に対するDIC診断クライテリア. 厚生省特定疾患汎発性血管内凝固症調査研究班, 昭和56年度業績報告集, 1982, p.4-14

• 30) 金山正明:肝機能と凝固異常. medicina 30:54-56, 1993

• 31) Bakker, C. M., Knot, EA, Stibbe, J. et al.:Disseminated intravascular coagulation in liver cirrhosis. J. Hepatol. 15:330-335, 1992
  pubmed

• 32) Matthes, K. B., Bleyl, H., Mathes, K. J. et al.:Coagulation activation in liver disease. Th romb. Res. 64:253-261, 1991

• 33) 川原田嘉文, 吉峰修時:肝臓疾患, 腹水, DIC, 消化管出血. 医学のあゆみ 別冊:54-56, 1993

• 34) 磯貝直史:凝固線溶マーカーの測定-FDP. 血液凝固検査ハンドブック (藤巻道夫, 福武勝, 幸編), 宇宙堂八木書店, 東京, 1992, p.329-342

P.229 掲載の参考文献

• 1) 谷札夫:分泌. 消化管機能 (中村孝司編), 1版, 中外医学社, 東京, 1988, p.183-243

• 2) 細田四郎:消化と吸収. Essential Lecture消化器 (竹本忠良ほか編), 1版, メジカルビュー社, 東京, 1985, p.49-55

• 3) 青柳利雄:肝疾患の消化・吸収に関する2, 3の知見. 消化と吸収 15:5-17, 1992

• 4) 福本陽平, 松田和也:慢性肝疾患における消化性潰瘍の発生機序について. Gastroenterol. Endosc. 28:1131-1133, 1986

• 5) Cappell, M. S., Price, J. B.:Characterization of the syndrome of small and large intestinal variceal bleeding. Dig. Dis. Sci. 32:422-427, 1987
  pubmed

• 6) Diner, W. C.:Small intestinal edema in cirrhosis:Its disappearance with diuresis. Radiology 91:792-794, 1968
  pubmed

• 7) 石綿宏敏:慢性肝障害と小腸の絨毛形態および二糖類分解酵素について. 日大医誌 37:1005-1023, 1978

• 8) Gallagher, C., Bonar, F., Dempsey, J. et al.:Small bowel capillary dilatation in portal hypertension. Postgrad. Med. J. 61:541-543, 1985
  pubmed

• 9) Eckardt, V. F., Grace, N. D.:Gastroesophageal reflux and bleeding esophageal varices. Gastroenterology 76:39-42, 1979
  pubmed

• 10) 周山秀昭:肝硬変患者における radioisotope 法による胃排出能の検討. 日消誌 81:2507-2515, 1984

• 11) Chesta, J., Defilippi, C., Defilippi, C.:Abnormalities in proximal small bowel motility in patientswith cirrhosis. Hepatology 17:828-832, 1993

• 12) Chesta, J., Lillo, R., Defilippi, C. et al.:Mouth to cacum transit time and solid meal gastric emptying in patients with liver cirrhosis. Rev. Med. Chil. 119:1248-1253, 1991

• 13) Ostrow, J. D., Timmermann, R. J., Gay, S. J.:Gastric secretion in human hepatic cirrhosis. Gastroenterology 38:393-313, 1960

• 14) 占部一喜:肝硬変症における胃液酸, ペプシンの検討. 日消誌 77:60-67, 1980

• 15) 福田益樹, 川野淳, 佐藤信紘ほか:肝硬変患者の胃粘膜血行動態および酸素需給動態の検討. 日消誌 83:26-32, 1986

• 16) Tanaka, M., Inatsuti, S., Terasaki, T. et al.:Duodenal mucosal hemodynamics in patients with lier cirrhosis. Acta Med. Okayama 44:273-277, 1990

• 17) 渡辺明治:肝硬変症における膵病態に関する研究. 第1編. 肝硬変症の膵外分泌機能について. 日消誌 64:823-834, 1967

• 18) 下河正行:肝硬変症における二糖類分解酵素活性の検討. 久留米医誌 50:117-123, 1987

• 19) Shindo, K., Machida, M., Miyakawa, K. et al.:A study of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption. Am. J. Gastroenterol. 88:2084-2091, 1993

• 20) Tsuchiya, M., Asakura, H., Mimura, S. et al.:Pathological and pathophysiological study on intes tinal lymphatic system in fat absorptions. Gastroenterol. Jpn. 15:247-252, 1980

• 21) Patteson, T. E., Vlalhcevic, Z. R., Schwartz, C. C. et al.:Bile acid metabolism in cirrhosis. Gastroenterol. 79:620-628, 1980

• 22) Bode, C., Goebell, H., Kehl, W.:Effect of cholecystokinin-pancredocymin on bile salt secretion into the duodenal juice in patients with liver cirrhosis.,Klin. VVsch r. 49:881-883, 1971

• 23) Badley, B. W., Murphy, G. M., Bouchier, I. A. D.:Diminished micellar phase lipid in patients with chronic nonalcoholic liver disease and steatorrhea. Gastroenterology 58:781-789, 1970

• 24) Sun, D. C. H., Albacete, R. A., Chen, J. K. et al.:Malabsoption studies in cirrhosis of the liver. A rch. Intern. Med. 119:567-571, 1967

• 25) Arakawa, T., Satoh, H., Fukuda, T. et al.:Endogenous prostaglandin E 2 in gastric mucosa of patients alcoholic cirrhosis and portal hypertension. Gastroenterology 93:135-140, 1987

• 26) Jacob, A. I., Goldberg, P. K., Boom, N.:Endotoxin and bacteria in portal blood. Gastroenterology 72:1268-1270, 1972

• 27) Walker, W. A.:Intestinal transport of macromolecules. In Physiology of the Gastrointestinal Tract (Johnson, L. R. ed.), Raven Press, New York, 1981, p. 1271-1289

• 28) Editorial:Antigen absorption by the gut. Lancet ii:715-717, 1978

• 29) 細田四郎:脂質, 胆汁酸吸収の病態生理. 新生理学大系18巻 (星猛, 藤田道也編), 第1版, 医学書院, 東京, 1988, p.363

• 30) 荒川泰行, 鈴木壱知, 竹内重雄:小腸の亜鉛吸収試験の臨床的意義. JJPEN 14:43-52, 1992

• 31) Merli, M., Caschera, M., Piat, C. et al.:The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis. J. Clin. Gastroenterol. 15:125-127, 1992
  pubmed

chapter5 免疫

P.248 掲載の参考文献

• 1) Von Boehmer, H., Kisielow, P.:How the immune system learns about self. Sci. Amer. 265:50-59, 1991

• 2) Davis, M. M., Bjorkman, P. J.:T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402, 1988

• 3) 柳雄介:T細胞レセプターと遺伝子. 現代免疫学 (山村雄一ほか編), 初版, 医学書院, 東京, 1988, p.39-47

• 4) 高垣洋太郎:T細胞レセプターと遺伝子. 現代免疫学 (山村雄一ほか編), 改訂第2版, 医学書院, 東京, 1992, p.50-64

• 5) Brenner, M. B., Strominger, J. L, Krangel, M. S.:The yδT cell receptor. Adv. Immunol. 43:133-192, 1988

• 6) Sha, W. C., Nelson, C. A., Newberry, R. D. et al.:Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73-76, 1988

• 7) Matsui, K., Boniface, J J., Reay, P. A. et al.:Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788-1791, 1991

• 8) Corr, M., Slanerz, A. E., Boyd, L. F. et al.:Tcell receptor-MHC class I peptide interactions:Affinity, kinetics, and specifictty. Science 265:946-949, 1994

• 9) 矢田純一:T細胞の活性化. リンパ球の免疫生物学, 初版, 中外医学社, 東京, 1993, p.54-76

• 10) Van Seventer, G. A., Shimizu, Y., Horgan, K. J. et al.:The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579-4586, 1990

• 11) Shwartz, R. H.:Acell culture model for T lymphocyte clonal anergy. Science 248:1349-1356, 1990

• 12) 矢田純一:T細胞の機能. リンパ球の免疫生物学, 初版, 中外医学社, 東京, 1993, p.77-100

• 13) 武井正美, 澤田滋正:IL-10. Annual Review免疫1992 (菊地浩吉ほか編), 中外医学社, 東京, 1992, p.124-130

• 14) 清水章:免疫グロブリンの遺伝子. 現代免疫学 (山村雄一ほか編), 初版, 医学書院, 東京, 1988, p.48-56

• 15) Tonegawa, S:Somatic generation of antibody diversity. Natzare 302:575-581, 1983
  pubmed

• 16) 市木康久, 村口篤:免疫グロブリンクラススイッチとサイトカイン. Annual Review 免疫1992 (菊地浩吉ほか編), 中外医学社, 東京, 1992, p.124-130

• 17) Ron, Y., Sprent, J.:Tcell priming in vivo:Amajor role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138:2848-2856, 1987

• 18) 矢田純一:マクロファージ. 免疫の細胞生物学. 初版, 中外医学社, 東京, 1985, p.88-115

• 19) 矢田純一:T細胞の抗原認識機構. リンパ球の免疫生物学, 初版, 中外医学社, 東京, 1993, p.21-41

• 20) Herberman, R. B., Ortaldo, J. R.:Natural killer cells:Their role in defenses against disease. Science 214:24-30, 1981
  pubmed

• 21) 熊谷勝男, 力石秀実:NK細胞とLAK細胞. 現代免疫学 (山村雄−ほか編), 改訂第2版, 医学書院, 東京, 1992, p.124-133

• 22) Cuturi, M. C., Anegon, J., Sherman, F. et al.:Production of hematopoietic colony stimulating factors by human natural killer cells. J. Exp. Med. 169:569-583, 1989
  pubmed

• 23) Nagler, A., Lanier, L. L, Cwira, S. et al.:Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143:3183-3191, 1989

• 24) 矢田純一:NK細胞. K細胞. リンパ球の免疫生物学, 初版, 中外医学社, 東京, 1993, p.159-169

• 25) Nagler, A., Lanier, L. L., Phillips, J. H.:Constitutive expression of high affinity interleukin 2 receptors on human CD 16-natural killer cells in vivo. J. Exp. Med. 171:1527-1533, 1990

• 26) Gately, M. L, Desai, B. B., Wolitzki, A. G.:Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) . J. Immunol. 147:874-882, 1991

• 27) Ohteki, T., Abo, T., Seki, S. et al.:Predominant appearance of y/δT lymphocytes in the liver of mice after birth. Eur. J. Immunol. 21:1733-1740, 1991

• 28) 安保徹, 渡辺久実, 櫺木俊聡ほか:T細胞の胸腺外分化. Annual Review 免疫1992 (菊地浩吉ほか編), 中外医学社, 東京, 1992, p.9-19

• 29) Seki, S., Kono, D. H., Balderas, R. S. et al.:V βrepertoire of murine hepatic T cells, Implication for selection of double negative αβ+ Tcells. J. Immunol. 53:637-646, 1994

• 30) Ohteki, T., Seki, S., Abo, T. et al.:Liver is a possible site for the proliferation of abnormal CD 3+4-8-double negative lymphocytes in autoimmune MRL-1 pr/1 pr mice. J. Exp. Med. 172:7-12, 1990

• 31) 田中正俊, 黒松亮子, 谷川久一:γδT 細胞と肝類洞. 肝胆膵 24:943-947, 1992

• 32) 安保徹, 関修司, 櫺木俊聡ほか:γδT 細胞の生体内機能. Annual Review免疫1991 (菊地浩吉ほか編), 中外医学社, 東京, 1991, p.39-46

• 33) Wisse, E., van:t Noordende, J. M., van der Meulen, J. et al.:The pit cell:Description of a new type of cell occuring in rat liver sinusoids and peripheral blood. Cell Tissue Res. 173:423-435, 1976
  pubmed

• 34) Bouwens, L., Wisse, E.:Immunoelectron microscopic characterization of large granular lymphocytes (natural killer cells) from rat liver. Ezar. J. Immunol. 17:1423-1428, 1987

• 35) Vanderkerken, K., Bouwens, L, Wisse, E.:Characterization of phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. Hepatology 12:70-75, 1990
  pubmed

• 36) Bouwens, L, Wisse, E.:Pit cells in the liver. Liver 12:3-9, 1992
  pubmed

• 37) Hata, K., Zhang, X. R., Iwatsuki, S. et al.:Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin. Immunol. Immunopathol. 56:401-419, 1990
  pubmed

• 38) Kaneda, K., Kurioka, N., Seki, S. et al.:Pit cell-hepatocyte contact in autoimmune hepatitis. Hepatology 4:955-958, 1984
  pubmed

• 39) Bouwens, L, Wisse, E.:Tissue localization and kinetics of pit cells or large granular lymphocytes in the liver of rats treated with biological response modifiers. Hepatology 8:46-52, 1988
  pubmed

• 40) Bouwens, L., Jakobs, R., Remels, L et al.:Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol. Immunother. 27:137-141, 1988

• 41) Ijzermans, J. N. M., Marquet, R. L., Bouwman, E. et al.:Successful treatment of colon cancer in rats with recombinant interferon-gamma. Br. J. Cancer 56:795-796, 1987

• 42) Shiratori, Y., Nakata, R., Okano, K. et al.:Inhibition of hepatic metastasis of colon carcinoma by asialo-GM 1-positive cells in the liver. Hepatology 16:469-478, 1992
  pubmed

• 43) Bukowski, J. F., Woda, B. A., Habu, S. et al.:Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131:1531-1538, 1983
  pubmed

• 44) 内藤真, 高橋潔:Kupffer細胞. 発生と分化. 肝胆膵 24:873-879, 1992

• 45) 白鳥康史:Kupffer細胞. 機能とその異常. 肝胆膵 24:881-888, 1992

• 46) Arii, S., Monden, K., Itai, S. et al.:Depressed function of Kupffer cells in rats with CCI4 induced liver cirrhosis. Res. Exp. Med. 190:172-182, 1990

• 47) Canalese, J., Gove, C. D., Gimson, A. E. et al.:Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 23:265-269, 1982
  pubmed

• 48) 持田智, 藤原研司:Kupffer細胞. 実験的肝障害における役割. 肝胆膵 24:889-899, 1992

• 49) Cantor, H. M., Dumont, A. E.:Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215:744-745, 1967
  pubmed

• 50) Triger, D. R., Cynamon, M. H., Wright, R.:Studies on hepatic uptake of antigen. 1. Comparison of inferior vena cava and portal vein routes of immunization. Immunology 25:941-950, 1973

• 51) Sano, S., Suda, T., Fujiwara, H. et al.:Abrogation of the capacity of delayed-type-hypersensitiv ity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells. J. immunol. 139:3652-3659, 1987

• 52) 藤原大美:肝による移植免疫の制御. Annual Review 免疫1988 (菊地浩吉ほか 編), 中外医学社, 東京, 1988, p.219-226

• 53) Calne, R. Y.:The present status of liver transplantation. Transplant. Proc. 9:209, 1977
  pubmed

• 54) Calne, R. Y., White, H. J. O., Yoffa, D. E. et al.:Prolonged survival of liver transplantation in the pig. Br. J. Med. 4:645-648, 1967

• 55) Kamada, N., Wight, D. G. D.:Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 38:217-221, 1984

• 56) Kamada, N., Muller, G. H., Katami, M. et al.:Sensitization of rats for rejection of heart allografts by heterotopic auxiliary liver grafting or administration of liver cell suspensions. Transplantation 40:106-108, 1985
  pubmed

• 57) 鎌田直司, 四宮貴久:実験的肝移植の免疫学. Annual Review 免疫1988 (菊地浩吉ほか編), 中外医学社, 東京, 1988, p.315-333

• 58) Miyazawa, K., Tsubouchi, H., Naka, D. et al.:Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163:967-973, 1989
  pubmed

• 59) 横室公三, 馬淵綾子, 坂本俊樹:肝再生の基礎と臨床. 免疫. 肝胆膵 21:1073-1081, 1990

• 60) 藤原研司, 名越澄子:肝再生と類洞壁細胞. Biomedica 6:55-58, 1991

• 61) Katsumoto, F., Miyazaki, K., Nakayama, F.:Stimulation of DNA synthesis in hepatocytes by Kupffer cells after partial hepatectomy. Hepatology 9:405-410, 1989
  pubmed

• 62) Nakamura, T., Arakai, R., Ichihara, A.:Interleukin-1 P is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp. Cell,Res. 179:488-497, 1988

• 63) Itoh, H., Abo, T., Sugawara, S. et al.:Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J. Immunol. 141:315-323, 1988
  pubmed

• 64) Saibara, T., Onishi, S., Sakaeda, H. et al.:Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma. Hepatology 9:471-476, 1989
  pubmed

• 65) Grimm, E, A., Mazumder, A., Zhang, H. Z. et al.:Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823-1841, 1982
  pubmed

• 66) Rubin, J. T., Elwood, LJ., Rosenberg, S. A. et al.:Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans. Cancer Res. 49:7086-7092, 1989
  pubmed

• 67) Yuh, K., Shimizu, M., Aoyama, S. et al.:Immunological analysis and characterization of lymphocyte subsets in specimens of human hepatocellular carcinomas and metastatic liver cancers. Cancer Immunol. immunother. 28:1-8, 1989
  pubmed

• 68) Shimizu, Y., Watanabe, A., Whiteside, T. L.:Memory T-lymphocytes are the main population oftumor-infiltrating lymphocytes obtained from human primary liver tumors. J. Hepatol. 16:197-202, 1992

• 69) Shimizu, Y., Iwatsuki, S., Herberman, R. B. et al.:Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors., Int. J. Cancer 46:878-883, 1990
  pubmed

• 70) Shimizu, Y., Iwatsuki, S., Herberman, R. B. et al.:Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer immunol. Immunother. 32:280-288, 1991
  pubmed

P.259 掲載の参考文献

• 1) Kojima, T., Bleomen, J., Desmet, V. J.:Immunoelectron microscopic demonstration of hepatitis B core antigen (HBsAg) in liver cell plasma membrane. Liver 7:191-200, 1987

• 2) Mondelli, M., Vergani, G. M., Alberti, A. et al.:Specificity of T lymphocyte cytotoxicity to autolo-gous hepatocytes in chronic hepatitis B virus infection:evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J. Immunol. 129:2773-2778, 1982

• 3) Inoue, M., Kakumu, S., Yoshioka, K. et al.:Hepatitis B core antigen-specific IFN-production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J. Immzanol. 142:4006-4011, 1989
  pubmed

• 4) Ferrari, C., Penna, A., Giuberti, T. et al.:Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J. Immunol. 139:2050-2058, 1987

• 5) Montano, L., Meischer, G. C., Goodall, A. H. et al.:Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B infection. Hepatology 2:557-561, 1982

• 6) Van den Oord, J. J., De vos, R., Desmet, V. J.:In situ distribution of major histocompatibility complex products and viral infection:Evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology 6:981-986, 1986
  pubmed

• 7) Aoyama, K., Kojima, T., Inoue, K. et al.:Immunohistochemical investigation of hepattitis B virus associated antigens, HLA antigens and lymphocyte subsets in type B chronic hepatitis. Gastroen terol. Jpn. 25:4153, 1990

• 8) Volpes, R., Van den Oord, J. J., Desmet, V. J.:Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 12:59-65, 1990
  pubmed

• 9) Franco, A., Barnaba, V., Natali, P. et al:Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 3:449-454, 1988

• 10) Kvale, D., Brandtzaeg, P.:Immune modulation of adhesion molecules ICAM-1 (CD 54) and LFA-3 (CD 58) in human hepatocytic cell lines. J. Hepatol. 17:347-352, 1993

• 11) 青山圭一, 小島隆, 松井俊二郎ほか:単クローン性抗体を用いた酵素抗体法による肝組織内 T cell sub-sets. 消化器と免疫 (土屋雅春 監), 第11集, 医歯薬出版, 東京, 1983, p.34-39

• 12) 西川温博:各種肝疾患におけるリンパ濾胞形成の意義-臨床病理学的検討を中心に. 肝臓 28:1428-1438, 1987

• 13) Hiramatsu, N., Hayashi, N., Katayama, K. et al.:Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359, 1994

• 14) Vento, S., Hegarty, J. E., Alberti, A. et al.:Tlymphocyte sensitization to HBsAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology 5:192-197, 1985

• 15) Vento, S., Chem, S. H., Giuliani-Piccari, G. et al.:Cullular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus. Immunology 62:593-598, 1987

• 16) Botarelli, P., Brinetto, M. R., Minutello, M. A. et al.:T-lymphocyte response to hepatitis C virus indifferent clinical courses of infection. J. Immunol. 147:3128-3132, 1991

• 17) Eddleston, A. L. W. F., Mondelli, M., Vergani, G. M. et al,:Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B infection. Hepatology 2:122S-127S, 1982

• 18) Moriyama, T., Guilhot, S., Klopchin, K. et al.:Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248:361-364, 1990
  pubmed

• 19) Barnaba, V., Franco, A., Alberti, A. et al.:Recognition of hepatitis B virus envelope proteins by liver infiltrating T lymphocytes in chronic HBV infection. J.. Immunol. 143:2650-2655, 1989
  pubmed

• 20) Koziel, M. J., Dudley, D., Wong, J. T. et al.:Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344, 1992
  pubmed

• 21) Kita, H., Moriyama, T., Kaneko, T. et al.:HLA-B 44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044, 1993

• 22) Erickson, A. L, Houghton, M., Choo, Q. L. et al.:Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic Hepatitis C. J. immunol. 151:4189-4199, 1993
  pubmed

• 23) Okamoto, H., Yotsumoto, S., Akehata, Y. et al.:Hepatitis B virus with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J. Virol. 64:1298-1303, 1990

• 24) Takeda, K., Akahane, Y., Suzuki, H. et al.:Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 12:1284-1289, 1990
  pubmed

• 25) Ehara, T., Omata, M., Chuang, W. L. et al.:Mutations in core nucleotide suquence of hepatitis B virus correlate with fulminant and severe hepatitis. J. Clin.,lnvest. 91:1206-1213, 1993

• 26) Yamauchi, K., Nakamura, T., Yonemitsu, H. et al.:Possible role of preS 2 peptides presented by MHC class I antigens in the pathogenesis of chronic hepatitis B. J. Hepatol. 17 (Suppl.):S6-S 9, 1993

• 27) Okada, S., Akahane, Y., Suzuki, H. et al.:The degree of variability in the amino terminal region of the E 2/NS 1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624, 1992

• 28) Okamoto, H., Kojima, M., Okada, S. et al.:Genetic drift of hepatitis C virus during an 8. 2-year infection in a chimpanzee:variability and stability. Virology 190:894-899, 1992

P.273 掲載の参考文献

• 1) Brown, J. H., Jardletzky, T., Saper, M. A. et al.:A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332:845-850, 1988
  pubmed

• 2) Bjorkman, P. J., Saper, M. A., Samrraoui, B. et al.:Structure of the human class 1 histocompatibility antigen, HLA-A 2. Nature 329:506-512, 1987

• 3) Bjorkman, P. J., Saper, M. A., Samraoui, B. et al.:The foreign antigen binding site and T cell re cognition region of class I histocompatibility antigens. Nature 329:512-518, 1987

• 4) 高垣洋太郎:T細胞レセプターと遺伝子. 現代免疫学 (山村雄一, 多田富男編), 医学書院, 東京, 1992, p.50-64

• 5) Chothia, C., Boswell, D. R., Lesk, A. M. et al.:The outline structure of the T-cell α β receptor. EMBO J. 7:3745-3755, 1988

• 6) Spranger, T. A.:Adhesion receptors of the immune system. Nature 346:425-434, 1990

• 7) 野島美久, 森本幾夫:免疫細胞と疾患. 現代免疫学 (山村雄一, 多田富男 編), 医学書院, 東京, 1992, p.290-300

• 8) Miller, J. F. A. P.:Immunological function of the thymus. Lancet 2:748-749, 1961

• 9) 藤原大美:胸腺内T細胞レセプター選択と細胞死. Jpn. J. Clin. Immunol. 16:451-457, 1993

• 10) Dellabona, P., Peccoud, J., Kappler, J. et al.:Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121, 1990
  pubmed

• 11) 阿部良:Mlsとスーパー抗原. 現代免疫学 (山村雄一, 多田富男 編), 医学書院, 東京, 1992, p.182-191

• 12) Gillis, S., Kozak, R., Durante, M. et al.:Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J. Clin. Invest. 67:937-942, 1981

• 13) Hayashi, Y., Utsuyama, M., Kurashima, C.:Spontaneous development of organ specific autoimmune lesions in aged C 57 BL/6 mice. Clin. Exp. immunol. 78:120-126, 1989

• 14) 渡辺文時, 奥秋靖, 戸田剛太郎ほか:自己免疫性肝炎の臨床像と免疫遺伝学的背景の再検討. 肝臓 7:287-295, 1993

• 15) Seki, T., Kiyosawa, K., Ota, M. et al:Association of autoimmune hepatitis with human leukocyte antigen BW 54 and DR 4 in Japanese patients. Hepatology 12:1300-1304, 1990

• 16) Manabe, K., Peter, T., Roger, W. et al.:Human leukocyte antigen Al-B8-DR3-DQ2-DPB180401 extended haplotype in autoimmune hepatitis. Hepatology 18:1334-1337, 1993

• 17) 渡辺恭行, 升田一成, 中西敏夫ほか:新生期胸腺摘出マウスにおける肝炎モデル. 自己免疫性肝疾患 (西岡幹夫編), 日本医学館, 東京, 1992, p.35-38

• 18) Manns, M. P., Gerken, G., Kryatsoulis, A. et al.:Characterization of a new subgroup of autoimmune hepatitis by autoantibodies against a soluble liver antigen. Lancet l:292-294, 1987

• 19) Stechemesser, E., Strienz, J., Berg, P. A.:Serological definition of new subgroup of patients with autoimmune chronic active hepatitis. Lancet 1:683, 1987
  pubmed

• 20) 池田有成, 橋本直明, 戸田剛太郎:自己免疫性肝炎. Medical Practice 8:427-430, 1991

• 21) Manns, M. P., Griffin, K., Sullivan, K. F. et al.:LKM-1 autoantibodies recognizes a short linear sequence in P 45011 D 6, a cytochrome P-450 monooxygenase. J. Clin. Invest. 88:1370-1378, 1991

• 22) 佐々木博:自己免疫性肝炎の肝組織内浸潤リンパ球の免疫組織学的検討. 厚生省難治性の肝炎調査研究班昭和61年度研究報告, 1987, p.145-150

• 23) 相澤良夫, 蔵本暁, 銭谷幹男ほか:自己免疫性肝炎における肝浸潤リンパ球. 日臨免誌 17:334, 1994

• 24) Demetris, A. J., Sever, C., Kakizoe, S. et al.:S100 protein positive dentritic cells in primary biliary cirrhosis and other chronic inflammatory liver disease. Relevance to pathogenesis? Am. J. Pathol. 134:741-747, 1980

• 25) 恩地森一, 四宮瑞穂, 灘野成人ほか:肝組織内におけるリンパ性樹状細胞の局在. 日臨免誌 17:475, 1994

• 26) 宮林千春, 樋口清博, 佐々木博:原発性胆汁性肝硬変. 臨床成人病 23:1676-1680, 1983

• 27) Yeaman, S. J., Danner, D. J., Mutimer, D. J. et al.:Primary biliary cirrhosis:identification of two major M 2 mitochondrial autoantigens. Lancet 1:1067-1070, 1988

• 28) Burroughs, A. K., Butler, P., Sternberg, M. J. E. et al.:Molecular mimicry in liver disease. Nature 358:377-378, 1992

• 29) 石川雅邦, 安達博保, 佐藤信紘ほか:PBCにおけるanti-M2対応抗原の意義. 日臨免誌 17:393, 1994

• 30) Miyabayashi, C., Matsui, S., Sasaki, H. et al.:Ultrastructural changes of biliary epitherial cells and basement membrane in primary billiary cirrhisis. J. Clin. Electron Microscopy 17:1041, 1984

• 31) James, O. F. W., Myszor, M.:Epidemiology and genetics of primary biliary cirrhosis. Progress in Liver Disease, 9 (Popper, H., Schaffer, F. eds.), WB Saunders Company, USA, 1990, p. 523-536

• 32) Bach, N., Schaffner, F.:Familial primary biliary cirrhosis. J. Hepatol. 20:698-701, 1994
  pubmed

• 33) 秋沢直明, 三浦徹, 大西三郎ほか:HLAが同一の姉妹に発症した抗ミトコンドリア抗体陰性, 抗核抗体強陽性の原発性胆汁性肝硬変. 肝臓 34:160, 1993

• 34) Seki, T., Kiyosawa, K., Inoko, H. et al.:Association of primary biliary cirrhosis with human leuko cyte antigen DPB 180501 in Japanese patients. Hepatol. 18:73-78, 1993

• 35) Wendy, L. G., Margaret, F. B.:Genetic factors in primary biliary cirrhosis. J. Hepatol. 20:689-692, 1994

P.285 掲載の参考文献

• 1) Reinecke, G., Pabst, R.:Subsets of blood, spleen and recirculating lymphocytes in man. Clin. Exp. immunol. 53:672-678, 1983
  pubmed

• 2) Dinarello, C. A.:Interleukin-1 and its biologically related cytokines. Adv. immunol. 44:153-205, 1989
  pubmed

• 3) Gauldie, J., Richards, C., Harnish, D. et al.:Interferon β2/B cell stimulatory factor type 2 sharesidentity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. 1) roc. Natl. Acad. Sci. USA 184:7251-7255, 1987

• 4) Andus, T., Geiger, T., Hirano, T. et al.:Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-β2) regulatesβ-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221:18-22, 1987

• 5) Geiger, T., Andus, T., Klapproth, J. et al.:Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18:717-721, 1988
  pubmed

• 6) Nijsten, N., De Groot, E. R., Ten Duis, H. J. et al.:Serum levels of interleukin-6 and acute phase responses.,Lancet 2:921, 1987

• 7) Ohzato, H., Monden, M., Yoshizaki, K. et al.:Systemic production of interleukin-6 following acute inflammation. Biochem. Biophys. Res. Commun. 197:1556-1562, 1993
  pubmed

• 8) Hack, C. E., De Groot, E. R., Richelle, J. F. et al.:Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710, 1989

• 9) Waage, A., Brandtzaeg, P., Halstensen, A. et al.:The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169:333-338, 1989
  pubmed

• 10) Khoruts, A., Stahnke, L., McClain, C. J. et al.:Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-276, 1991
  pubmed

• 11) Deviere, J., Content, J., Denys, C. et al.:High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines pro duction. Clin. Exp. immunol. 77:221-225, 1989

• 12) 舛本俊一, 恩地森一, ファズレアクバルほか:慢性ウイルス肝炎の病態におけるインターロイキン-8の関与. 消化器疾患とサイトカイン (西岡幹男ほか編), 日本医学館, 東京, 1993, p.51-53

• 13) Sheron, N, Bird, G., Koskinas, J. et al:Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41-46, 1993
  pubmed

• 14) Tilg, H., Vogel, W., Wiedermann, C. J. et al.:Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology 18:1132-1138, 1993
  pubmed

• 15) 福井博, 辻田重信, 北野浩行ほか:肝硬変における血中サイトカインとエンドトキシン. 消化器疾患とサイトカイン (西岡幹男ほか編), 日本医学館, 東京, 1993, p.67-71

• 16) Tilg, H., Wilmer, A., Vogel, W. et al.:Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
  pubmed

• 17) 湯浅圭一朗, 新井孝之, 山田昇司:急性肝障害マウスにおける脾内増生細胞の組織化学的検討. 日消誌 87:989-996, 1990

• 18) 筒井ひろ子, 溝口靖紘, 宮島慶治ほか:実験的に急性肝不全を誘導したマウスの脾細胞におけるインターリューキン1および2の産生について. 日消誌 84:1090-1096, 1987

• 19) 大越裕文, 銭谷幹男, 河辺朋信ほか:実験的急性肝障害モデルにおける脾臓の役割に関する研究. 肝臓 30:559-566, 1989

• 20) 筒井ひろ子, 宮島慶治, 溝口靖紘ほか:実験的に誘導した急性肝不全マウスに認められる肝細胞障害因子の性状について. 日消誌 83:1161-1167, 1986

• 21) 柿坂明俊, 葛西眞一, 工藤浩市ほか:急性肝不全に対する外因性cyclic AMPの投与効果及び脾臓の役割に関する実験的研究. 肝臓 33:925-931, 1992

• 22) Muller, A. F., Toghill, P. J.:Splenic function in alcoholic liver disease. Gut 33:1386-1389, 1992
  pubmed

• 23) Tanaka, S., Kumashiro, R., Tanikawa, K.:Role of the spleen in endotoxin-induced hepatic injury in chronic alcohol-fed rats. Liver 12:306-310, 1992
  pubmed

• 24) Castilla, A., Prieto, J., Fausto, N.:Transforming growth factor β1 and α in chronic liver disease. Effects of interferon alpha therapy. N. Engl. J. Med. 324:933-940, 1991

• 25) Chojkier, M., Brenner, D. A.:Therapeutic strategies for hepatic fibrosis. Hepatology 8:176-182, 1988
  pubmed

• 26) 宮崎寛, 佐多斉, 河辺朋信ほか:肝線維化進展における脾臓の役割に関する検討. 肝臓 29:703-704, 1988

• 27) Sangro, B., Bilbao, I., Herrero, I. et al.:Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18:309-314, 1993
  pubmed

• 28) 種村廣巳, 佐治董豊, 竹腰知治ほか:担癌生体における脾摘の功罪に関する実験. 日外会誌 84:982-985, 1983

• 29) Yamagishi, H., Pellis, N. R., Kahan, B. D.:Effect of splenectomy upon tumor growth. Characterizaion of splenic tumor-enhancing cells in vivo. Surgery 87:655-661, 1980

• 30) Yamaguchi, Y., Halperin, E. C., Harland, R. C. et al.:Significant prolongation of hamster liver transplant survival in Lewis rats by total-lymphoid irradiation, cyclosporine, and splenectomy. Transplantation 49:13-17, 1990
  pubmed

• 31) Valdivia, LA., Monden, M., Gotoh, M. et al.:Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation 44:759-763, 1987
  pubmed

• 32) Monden, M., Valdivia, L. A., Gotoh, M. et al.:Acrucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine. Surgery 105:535-542, 1989

• 33) Meiser, B. M., Morris, R. E.:The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation. Transplantation 51:690-696, 1991

• 34) Vanderkerken, K., Bowens, L., Wisse, E.:Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (Pit cells) in rat liver sinusoids. Hepatology 12:70-75, 1990

• 35) Vanderkerken, K., Bowens, L., De Neve, W. et al.:Origin and differentiation of hepatic natural killer cells (Pit cells) . Hepatology 18:919-925, 1993

• 36) Winnock, M., Garcia-Barcina, M., Huet, S.:Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 105:1152-1158, 1993
  pubmed

• 37) 奥野清隆, 大西博昭, 中嶋一三ほか:Interleukin-2 (IL-2)-Cyclophosphamide (CY) 脾動注による肝転移予防とIL-2-Mitomycin C (MMC), 5-Fluorouracil (5-Fu) 併用肝動注による肝転移治療. 日外会誌 92:1229-1233, 1991

• 38) Henney, C. S., Kuribayashi, K., Kern, D. E. et al.:Interleukin-2 augments natural killer cell activity. Nature 291:335-338, 1981
  pubmed

• 39) Dempsey, R. A., Dinarello, C. A., Mier, J. W. et al.:The differential effects of human leukocytic pyrogen/lymphocyte-activatinig factor, T cell growth factor, and interferon on human natural killer activity. J. immunol. 129:2504-2519, 1982
  pubmed

• 40) 大森浩二, 山岸久一, 岡隆宏:術中OK-432脾臓内投与による肝転移予防の検討. 癌と化学療法 19:1445-1448, 1992
  Medical*Online

• 41) 水戸廸郎:肝臓機能の再建を志した-外科医の足跡-人工肝・部分肝・肝細胞移植をめぐって-. 日小外会誌 28:253-262, 1992

• 42) 草野満夫, 水戸廸郎:肝細胞移植の研究. 日本臨牀 50:1679-1688, 1992
  Medical*Online

• 43) Ponder, K. P., Gupta, S., Leland, F. et al.:Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88:1217-1221, 1991
  pubmed

chapter6 細胞増殖

P.306 掲載の参考文献

• 1) Barker, D., Schafer, M., White, R.:Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36:131-138, 1984
  pubmed

• 2) Harding, D., Jeremiah, S. J., Povey, S. et al.:Chromsomal mapping of a human phenol UDP-glucuronosyltransferase, GNTI. Am. J. Hum. Genet. 54:17-21, 1990

• 3) Ritter, J. K., Chen, F., Sheen, Y. Y. et al.:Anovel complex locus UG TI encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol Chem. 267:3257-3261, 1992

• 4) Shih, C., Weinberg, R. A.:Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29:161-169, 1982
  pubmed

• 5) Parada, L. F., Tabin, C. J., Shih, C. et al.:Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297:474-478, 1982
  pubmed

• 6) Knudson, A. G. Jr.:Mutation and cancer:Statistical study of retinoblastoma. Proc. Na tl. Acad. Sci. USA 68:820-823, 1971

• 7) Friend, S. H., Bernards, R., Rogelj, S. et al.:Ahuman DNA segment with properties of the gene that predispose to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986

• 8) Levine, A. J., Momand, J., Finlay, C. A. et al.:The p 53 tumour suppressor gene. Nature 351:453-456, 1991

• 9) Fearon, E. R., Vogelstein, B.:A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
  pubmed

• 10) Aaronson, S. A.:Growth factors and cancer. Science 254:1146-1153, 1991
  pubmed

• 11) Bottaro, D. P., Rubin, J. S., Faletto, D. L. et al.:Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804, 1991

• 12) Shi, Y., Glynn, J. M., Guilbert, L. J. et al.:Role for c-myc in activation induced apoptotic cell death in T cell hybridomas. Science 257:212-214, 1992

• 13) Bissonnette, R. P., Echeverri, F., Mahboubi, A. et al:Apoptotic cell death induced by c-myc is inhibited by bcl-2. Natu re 359:552-554, 1992

• 14) Kastan, M. B., Onyekwere, O., Sidransky, D. et al.:Panicipation of p 53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311, 1991

• 15) Lowe, S. W., Schmitt, E. M., Smith, S. W. et al.:p 53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 199

P.320 掲載の参考文献

• 1) Higgins, G. M., Anderson, R. M.:Experimental pathology of the liver, 1:Restoration of the liver the white rat following partial surgical removal. Arch. Pathol 12:186-202, 1931

• 2) Bucher, N.:Regeneration of the liver in parabiotic rats. Cancer Res 11:457-465, 1951
  pubmed

• 3) Nakamura, T., Nawa, K., Ichihara, A.:Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rat. Biochem., Res. Res. Commun. 122:1450-1459, 1984
  pubmed

• 4) Nakamura, T., Nishizawa, T., Hagiya, M. et al.:Molecular cloning and expression of human hepatocyte growth factor. J Nature 342:440-443, 1989

• 5) Watanabe, A., Shiota, T., Higashi, T. et al.:Pleomorphism of hepatic regeneration. Res. Exp. Med. 184:49-57, 1984

• 6) Milandri, M., Gaub, J., Ranek, L.:Evidence for liver cell proliferation during fatal acute liver failure. Gut 21:423-427, 1980
  pubmed

• 7) Leffert, H. L., Koch, K., Shapiro, P. et al.:Cirrhosis of the Liver. (Tygstrup, N., Orlandi, R. eds.), Elsevier, Amsterdam, 1987, p. 121-140

• 8) 森道夫, 榎本克彦, 澤田典均:肝再生の形態学. BIO medica 6:1146-1150, 1991

• 9) Nakamura, T., Nakayama, Y., Ichihara, A.:Reciprocal modulation of growth and liver functions of mature rat hepatocytes in primary culture by anextract of hepatic plasma membranes. J. Biol. Chem. 258:8056-8058, 1984

• 10) Nakamura, T., Nakayama, Y., Ichihara, A.:Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocyte in primary culture. Proc. Natl. Acad. Sci. USA 83:6489-6493, 1986

• 11) Tsubouchi, H., Hirono, S., Gohda, E. et al.:Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hopatology 9:875-881, 1989
  pubmed

• 12) Zarnegar, R., DeFrances, M., Michalopoulos, G. K.:Localization of the human HGF gene on chromosome. Genomics 12:147-150, 1992

• 13) Tashiro, K., Hagiya, H., Nishizawa, T. et al.:Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA 87:3200-3204, 1990

• 14) Noji, S., Tashiro, K., Koyama, E. et al.:Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers as revealed by in situ hybridization. Biochenz. Biophys. Res. Commun. 173:42-47, 1990
  pubmed

• 15) Bottaro, D. P., Rubin, J. S., Faletto, D. L. et al.:Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804, 1991

• 16) Higuchi, O., Nakamura, T.:Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem. Biophys. Res. Commun. 176:599-607, 1991
  pubmed

• 17) Boix, L, Rosa, J. L., Ventura, F. et al.:c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology 19:88-91, 1994

• 18) Nakamura, T., Nawa, K., Ichihara, A. et al.:Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:311-316, 1987
  pubmed

• 19) Kinoshita, T., Tashiro, K., Nakamura, T.:Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem. Biophys. Res. Commun. 165:1229-1234, 1989
  pubmed

• 20) Hamanoue, M., Takao, S., Shimazu, H. et al.:Rapid and marked induction of hepatocyte growthfactor during liver regeneration after ischemic or crush injury. Hepatology 16:1485-1492, 1992
  pubmed

• 21) Lindroos, P. M., Zarnegar, R., Michalopoulos, G. K.:Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial he-patectomy and carbon tetrachloride administration. Hepatology 13:743-750, 1991

• 22) Asami, O., Ihara, I., Shimizu, N. et al.:Purification and characterization of hepatocyte growth factor from injuryed liver of carbon tetrachloride-treated rats. J. Biochem. 109:8-13, 1991

• 23) Appasamy, R., Tanabe, M., Murase, N. et al.:Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab. Invest. 68:270-276, 1993
  pubmed

• 24) Kinoshita, T., Hirao, S., Matsumoto, K. et al.:Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem. Biophys. Res. Commun. 177:330-335, 1991
  pubmed

• 25) Ishiki, Y., Ohnishi, H., Muto, Y. et al.:Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16:1227-1235, 1992

• 26) Webber, E. M., Godowski, P. J., Fausto, N.:In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 19:489-497, 1994

• 27) Shiota, G., Wang, T. C., Nakamura, T. et al.:Hepatocyte growth factor in transgenic mice:effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 19:962-972, 1994

• 28) Johnson, M., Koukoulis, G., Matsumoto, K. et al.:Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology 17:1052-1061, 1993
  pubmed

• 29) Tajima, H., Matsumoto, K., Nakamura, T.:Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett. 291:229-232, 1991
  pubmed

• 30) Matsumoto, K., Hashimoto, K., Yashikawa, K. et al.:Marked stimulation of growth and motility of human keratiocytes by hepatocyte growth factor. Exp. Cell Res. 196:114-120, 1991

• 31) Montesano, R., Schaller, G., Orci, L.:Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66:697-711, 1991
  pubmed

• 32) Tomita, T., Nagoshi, S., Fujiwara, K.:Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 15:1-4, 1992

• 33) Tsubouchi, H., Niitani, Y., Hirono, S. et al.:Level of the human hepatocyte growth factor in serum of patients with verious liver disease determined by an enzyme-linked immunosorbent assay. Hepatology 13:1-5, 1991

• 34) Cohen, S.:Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyeled opening in the newborn animal. J. Biol. Chem. 237:1555-1562, 1962
  pubmed

• 35) Scott, J., Urdea, M., Quiroga, M. et al.:Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 221:236-240, 1983
  pubmed

• 36) Ullrich, A., Coussens, L, Hayflick, J. S. et al.:Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A 431 epidermoid carcinoma cells. Nature 309:418-425, 1984

• 37) Marquardt, H., Hunkapiller, M. W., Hood, LE. et al.:Rat transforming growth factor type 1:structure and relation to epidermal growth factor. Science 223:1079-1082, 1984
  pubmed

• 38) Lee, D. C., Rose, T. M., Webb, N. R. et al.:Cloning and sequence analysis of a cDNA for rat transforming growth factor-α. Nature 313:489-491, 1985

• 39) Lee, D. C., Rochfold, R., Todaro, G. J. et al.:Developmental expression of rat transforming growth factor-α mRNA. Mol. Cell. Biol. 5:3644-3646, 1985

• 40) Mead, J. E., Fausto, N.:Transforming growth factor TGF α may physiological regulator of Iiver regeneration by means of an autocrine mechanism. Proc. Natl., Acad. Sci. USA 486:1558-1562, 1989

• 41) Tomiya, T., Fujiwara, K.:Serum levels of transforming growth factor-α in patients after partial epatectomy as determined with an enzyme-linked immunosorbent assay.,Uepatology 18:304-308, 1993

P.330 掲載の参考文献

• 1) DeLarco, J., Tadaro, G. J.:Growth factors from murine sarcoma virus transformed cells. Proc. Natl Acad. Sci. USA 75:4001-4005, 1978

• 2) Roberts, A. B., Sporn, M. B.:Handbook of Experimental Pharmacology (Sporn, M. B., Robert, A. B. eds.), Springer-Verlag, Berlin, 1990, p. 419-472

• 3) Devynck, R., Jarrett, J. A., Chen, E. Y. et al.:Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985

• 4) Massague, J.:Receptors for the TGF-β family. Cell 69:1067-1070, 1992

• 5) Mathews, L. S., Vale, W. W.:Expression cloning of an activin receptor, a predicted transmembrane serine. Cell 65:973-982, 1991
  pubmed

• 6) Attisano, L, Wrana, J. L., Cheifetz, S. et al.:Novel activin receptors:distinct genes and alternative mRNA splicing generate a repertoive of serine/threonine kinase receptors. Cell 68:97-108, 1992
  pubmed

• 7) Paralkar, V. M., Hammonds, R. G., Reddi, A. H.:Identification and characterization of cellular proteins (receptors) for recombinant human bone morphogenetic protein 2 B, an initiator of bone diferentiation cascade. Proc. Natl. Acad. Sci. USA 88:3397-3401, 1991

• 8) Lopez-Casillas, F., Cheifetz, S., Doody, J.:Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785-795, 1991

• 9) Wang, X.-F., Lin, H. Y., Ng-Eaton, E. et al.:Expression, cloning and characterization of the TGF-β type III receptor. Cell 67:797-805, 1991

• 10) Lopez-Casillas, F., Wrana, J. L., Massague, J.:Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73:1435-1444, 1993

• 11) Cheifetz, S., Bellon, T., Cales, S. et al.:Endoglin is a component of the TGF-β receptor system in human endothelial cells. J. Biol. Chem. 267:19027-19030, 1992

• 12) Lin, H. Y., Wang, X.-F., Ng-Eaton, E. et al.:Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992

• 13) Estevez, M., Attisano, L, Wrana, T. et al.:The daf-4 gene controls C. elegans daver larva development, encoding a BMP receptor. Nature 365:644-649, 1993

• 14) Ullric, A., Schlessinger, J.:Signal transdution by receptors with tyrosine kinase activity. Cell 61:203-212, 1990

• 15) Wrana, J. L, Attisano, L., Carcamo, T. et al.:TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014, 1992

• 16) Inagaki, M., Moustakes, A., Lin, H. Y. et al.:Growth inhibition by transforming growth factor type l recepter is restored in TGF-β resistant hepatoma cells after expression of TGF-β receptortype II cDNA. Proc. Natl. Acad. Sci. USA 90:5359-5363, 1993

• 17) Matsuzaki, K., Xu, T., Wang, F. et al.:Asidely expressed transmembrane serine/threonine kinase that does not bind activin, inhivin, transforming growth factorβ, or bone morphogenic factor. J. Biol. Chem. 268:12719-12723, 1993

• 18) Ebner, R., Chen, R.-P., Shum, L. et al.:Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:1344-1348, 1993

• 19) Ebner, R., Chen, R.-P., Lawler, S. et al.:Determination of type I receptor specificty by type II receptors for TGF-βor activin. Science 262:900-902, 1993

• 20) Attisano, L., Carcamo, J., Verrtura, F. et al.:Identification of human activin and TGF-β type I receptors that form heteromelic kinase complexes with type II receptors. Cell 75:671-680, 1993

• 21) He, W. W., Gustafson, M. L, Hirobe, S. et al.:Developmental expression of four novel serine/ threonine kinase receptors homologus to the activin/transforming growth factor-β type II receptor family., Dev. Dyn. 196:133-142, 1993

• 22) Dijke, P. T., Ichijo, H., Franzen, P. et al.:Activin receptor-like kinases:anovel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887, 1993

• 23) Bassing, C. H., Yingling, J. M., Howe, D. J. et al.:Atransforming growth factor β type I receptor that signals to activate gene expresion. Science 263:87-89, 1994

• 24) Fauso, N., Mead, J. E.:Regulation of liver growth:Protooncogenes and transforming growth factors. Lab. Invest. 60:4-13, 1989

• 25) Michalopoulos, G. K.:Liver regeneration:molecular mechanisms of growth control. FASEB J. 4:176-187, 1990
  pubmed

• 26) Carr, B. I., Hayashi, I., Branum, E. L. et al.:Inhibition of DNA synthesis in rat hepatocytes by platelet-drived typeβtransforming growth factor. Cancer Res. 46:2330-2334, 1986

• 27) Russell, W. E.:Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophoshorylation. J. Cell. Physiol. 135:233-261, 1988

• 28) Braun, L, Mead, J. E., Panzica, M. et al.:Transforming growth factor-β mRNA increases during liver regeneration:apossible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 85:1539-1543, 1988

• 29) Russell, W. E., Coffey, R. J., Ouellette, A. J. et al.:Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85:5126-5130, 1988
  pubmed

• 30) Nakatsukasa, H., Nagy, P., Evarts, R. P. et al.:Cellular distribution of transforming growth factor-β1 and procollagen type I,III, and IV transcripts in carbon tetrachloride induced rat liver fibrosis. J. Clin. Invest. 85:1833-1843, 1990

• 31) Castilla, A., Prieto, J., Fausto, N.:Transforming growth factor β1 and α therapy. N. Engl. J. Med. 324:933-940, 1991

• 32) Matsuzaki, M., Tsukamoto, H.:Stimulation of hepatic lipocyte collagen production by Kupffer cell derived transforming growth factor beta:implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11:599-605, 1990

• 33) Rieder, H., Armbrust, T., Bushenfelde, K.-H. M. et al.:Contribution of sinusoidal endothelial liver cells to liver fibrosis:expression of transforming growth factor-β1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-β1. Hepatology 18:937-944, 1993

• 34) Chen, R.-H., Ebner, R., Derynck, R.:Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260:1335-1338, 1993

P.346 掲載の参考文献

• 1) Shafritz, D. A., Shouval, D., Sherman, H. et al.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med. 305:1067-1073, 1981
  pubmed

• 2) 日本肝癌研究会:第10回全国原発性肝癌追跡調査報告(1988-1989). 日本肝癌研究会, 進行印刷出版, 京都, 1992

• 3) Takada, A., Nei, J., Takase, S. et al.:Effects of ethanol on experimental hepatocarcinogenesis. Hepato logy 6:65-72, 1986

• 4) 堤幹宏, 高田昭:アルコールと発癌. 日本内科学大系50肝癌 (井村裕夫ほか 編), 中山書店, 東京, 1991, p.26-30

• 5) Bressac, B., Kew, M., Wands, J. et al.:Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431, 1991

• 6) Hsu, I. C., Metcalf, R. A., Sun, T. et al.:Mutational hot spot in the p53 gene in human hepatocellular carcinoma. Nature 350:427-428, 1991

• 7) Ohta, M.:Experimental studies on hepatocarcinogenesis induced by oral contraceptives, with special reference to estrogen receptor and the effect of tamoxifen. Acta Hepatol. Jpn. 28:912-921, 1987

• 8) Berenblum, I.:The mechanism of carcinogenesis, a study of the significance of cocarcinogenic action and related phenomena. Cancer Res. 1:807-814, 1941

• 9) Popper, H., Roth, L, Gerin, J. et al.:Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc. Natl Acad. Sci USA. 84:866-870, 1987
  pubmed

• 10) Yasui, H., Hino, O., Ohtaku, K. et al.:Clonal growth of hepatitis B virus-integrated hepatocyte in cirrhotic liver nodules. Cancer Res. 52:6810-6814, 1992

• 11) Fearon, E. R., Vogelstein, B.:A genetic model for colorecal tumorigenesis. Cell 61:759-767, 1990

• 12) Ochiya, T., Fujiyama, A., Fukushige S. et al.:Molecular cloning of an oncogene from human hepatocellular carcinoma. Proc. Natl., Acad. Sci. US 483:4993-4997, 1986

• 13) Yuasa, Y., Sudo, K.:Transforming genes in human hepatomas detected by a tumorigenicity assay. Jpn. J. Cancer Res. 78:1036-1040, 1987
  pubmed

• 14) Dubois, R. D.:Early changes in gene expression during liver regeneration:What do they mean? Hepatology 11:1079-1082, 1990
  pubmed

• 15) Himeno, Y., Fukuda, Y., Hatanaka, M. et al:Expression of oncogenes in human liver disease. Liver 8:208-212, 1988
  pubmed

• 16) Aiba, N., Nambu, S., Inoue, K. et al.:Hypometylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis. Gastroenterol. Jpn. 24:270-276, 1989

• 17) 小川勝洋:綜説:化学肝発癌機序の分子生物学的研究の動向. 日本臨牀 51:386-393, 1993
  Medical*Online

• 18) Bottaro, D. P., Rubin, J. S., Faletto, D. L. et al.:Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804, 1991

• 19) Hsu, T. Y., Moroy, T., Etienble, J. et al.:Activation of c-myc by woodchuck hepatitis virus infection in hepatocellular carcinoma. Cell 55:627-635, 1988

• 20) Fourel, G., Trepo, C., Bougueleret, L. et al.:Frequent activation of N-myc genes by hepadna virus insertion in woodchuck liver tumours. Nature 347:294-298, 1990

• 21) Tada, M., Omata, M., Ohto, M.:Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res. 50:1121-1124, 1990
  pubmed

• 22) Simon, D., Knowles, B. B., Weith, A.:Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765-770, 1991
  pubmed

• 23) Zhang, W., Hirohashi, S., Tsuda, H. et al.:Frequent loss of heterozygosity of chromosome 16 and 14 in human hepatocellular carcinoma. Jpn. J. Cancer Res. 81:108-111, 1990
  pubmed

• 24) Wang, H. P., Rogler, C. E.:Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet. 48:72-78, 1988
  pubmed

• 25) Fujimori, M., Tokino, T., Hino, O. et al.:Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:89-93, 1991
  pubmed

• 26) Emi, M., Fujiwara, Y., Nakajima, T. et al.:Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 52:5368-5372, 1992
  pubmed

• 27) Fujimoto, Y., Hampton, L. L., Luo, L. et al.:Low frequency of p53 gene mutation in tumor induced by aflatoxin Bl in nonhuman primates. Cancer Res. 52:1044-1046, 1992

• 28) Oda, T., Tsuda, H., Scarpa, A. et al.:p53 gene mutation spectrum in hepatocellular carcinoma. Cancer,Res. 52:6358-6364, 1992
  pubmed

• 29) Tsuda, H., Zhang, W., Shimosato, Y. et al.:Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6791-6794, 1990
  pubmed

• 30) Murakami, Y., Hayasi, K., Hirohashi, S. et al.:Aberrations of the tumor suppressor genep53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51:5520-5525, 1991

• 31) Okuda, K.:Hepatocellular carcinoma:Recent progress. Hepatology 15:948-963, 1992
  pubmed

• 32) Twu, J. S., Schloemer, R. H.:Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61:3448-3453, 1987
  pubmed

• 33) Takada, S., Koike, K.:Xprotein of hepatitis B virus resembles a serine protease inhibitor. Jpn. J. Cancer Res. 81:1191-1194, 1990

• 34) Kekule, A. S., Lauer, U., Meyer, M. et al.:The preS 2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457-461, 1990

• 35) Hino, O., Kitagawa, T., Nomura, K. et al.:Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV 40 T antigen gene. Jpn. J. Cancer Res. 82:1226-1233, 1991
  pubmed

• 36) Small, J. A., Khoury, G., Jay, G. et al:Early regions of JC virus and BK virus induced distinct and tissue-specific tumors in transgenic mice. Proc. Natl. Acad. Sci. USA 83:8288-8292, 1986
  pubmed

• 37) Chisari, FV., Klopchin, K., Moriyama, T. et al.:Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156, 1989
  pubmed

• 38) Kim, C. M., Koike, K., Saito, I. et al.:HBx gene of hepatitis B virus induced Iiver cancer in transgenic mice. Nature 351:317-320, 1991

• 39) Koike, K., Moriya, K., Iino, S. et al.:High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819, 1994

• 40) Geller, S. A., Nichols, W. S., Kim, S. et al.:Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1 antitrypsin transgenic mice:Histopathological and DNA ploidy studies. Hepatology 19:389-397, 1994